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Abstract 
Inorganic phosphorus is a mineral found in all human tissues that associated with 
oxygen, becomes a phosphate anion (PO4
3-). Phosphate is involved in structural and regulatory 
purposes and its distribution covers soft tissues, extracellular fluids and the large majority is 
located in skeletal tissues.  
Phosphate absorption into the human body is realized by NaPi-IIb cotransporter in small 
intestine, and its excretion and reabsorption is mediated by NaPi-IIa cotransporter in kidney. 
This movement into the cell is mediated by SLC34 family and SLC20 family of cotransporters. 
This family comprehends PiT-1 and PiT-2 proteins that have a housekeeping role in cellular Pi 
homeostasis. Recently associated with a more specific physiological role, it has been showed 
their function in bone and parathyroid metabolism and mostly in cell proliferation and mitosis 
activity. 
This work aimed to evaluate tissue localization and expression of SLC20 in mouse 
model, and attempt to establish functional role of extracellular phosphate and cotransporters in 
normal and abnormal cell development and proliferation. To accomplish this purpose it were 
performed quantitative real-time PCR analyses, modulated phosphate availability assays in cell 
culture and uptake of phosphate assays in leukemic thymic cells. 
Altogether, it was confirmed the higher number of cells existent in a leukemic thymus 
comparing with wild-type. These results suggested that all the phosphate conditions above or 
below 6 mM resulted in a reduced cell proliferation, being also related with the duration time 
that cells where exposed to those conditions. It was also shown that intracellular phosphate 
homeostasis depends only on the amount of phosphate in the extracellular medium, higher the 
Pi higher the uptake. Lastly, gene expression in different phosphate conditions over time 
showed that PiT-1 and PiT-2 appear to be important for EL-4 cell proliferation, although their 
specific role was not investigated. Interestingly, XPR1 showed a prospective role as Pi exporter 
and α-klotho as an aging suppressor. 
 
Keywords: phosphate, SLC20 cotransporters, cell proliferation, thymus and leukemia. 
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Resumo 
O fósforo inorgânico é um mineral essencial encontrado em todos os tecidos e que está 
normalmente associado com oxigénio sob a forma de anião de fosfato (PO4
3-). O fosfato 
desempenha diversas funções a nível estrutural, estando incorporado por exemplo no ADN, 
fosfolípidos e fosfoproteínas. Também executa funções a nível regulador estando envolvido em 
diferentes mecanismos celulares, como vias de sinalização e crescimento. A sua distribuição 
abrange os tecidos conectivos e fluídos extracelulares, mas na sua maioria está localizado nos 
tecidos ósseos. 
O fosfato entra no organismo a partir do intestino delgado. Esta absorção é realizada 
pelo cotransportador NaPi-IIb, e ao mesmo tempo a sua excreção através da urina e a reabsorção 
é realizada no rim, no túbulo proximal, pelo cotransportador NaPi-IIa. Este simultâneo 
mecanismo de absorção, excreção e reabsorção mantém o organismo num estado de equilíbrio, 
com trocas entre o meio intracelular e o fosfato armazenado no meio extracelular. Este estado 
de equilíbrio é também atingido com a ajuda da hormona paratiroide (PTH), do fator de 
crescimento fibroblástico 23 (FGF23) e da vitamina D, e quando a sua função e/ou produção 
fica comprometida pode resultar em diversas patologias.  
Este movimento do fosfato para o interior das células é mediado pelos cotransportadores 
dependentes de sódio acima mencionados que pertencem à família transportadora de soluto 
SLC34 e também pela família transportadora de soluto SLC20. Esta família é composta por 
PiT-1 e PiT-2, dois cotransportadores com um vasto padrão de expressão que lhes confere a 
função de gestores da homeostasia de fosfato a nível celular, mantendo a entrada e saída de 
fosfato das células contante e de acordo com a necessidade do organismo.  
Associada a esta conhecida função de transporte, também existe a hipótese dos 
transportadores da família SLC20 terem a função de sensores de fosfato tendo em conta as 
semelhanças com o transportador de fosfato da Escherichia coli e da Saccharomyces cerevisiae. 
Independentemente da função de transporte, também têm vindo ultimamente a ser estudadas 
novas funções relacionadas com o metabolismo do osso, com a sua função na paratiroide e por 
fim a mais importante, com a sua função na proliferação celular e propagação da mitose. Estes 
últimos estudos foram realizados por Beck e colegas usando a retirada de PiT-1 que mostrou a 
repressão da proliferação celular em células HeLa. 
7 
 
Este trabalho tinha como objetivo avaliar os níveis de expressão e consequente 
localização a nível tecidual, dos genes PiT-1 e PiT-2, da família transportadora de soluto SLC20 
no modelo de ratinho. Também outros genes relacionados com transporte de fosfato foram 
investigados. O XPR1 que é associado como possível transportador de fosfato no lado 
basolateral da célula, e o α-klotho, recentemente associado com a possível função de anti 
envelhecimento e supressão tumoral. O trabalho tinha também como objetivo estabelecer a 
função do fosfato e respetivos cotransportadores no desenvolvimento e proliferação de células 
normais e tumorigênicas, verificando a diferença nestes dois tipos celulares.  
Para realizar estas metas propostas foi efetuada a quantificação por Real-Time PCR dos 
genes de interesse a partir do ARN extraído de diferentes tecidos previamente recolhidos, 
avaliando a sua distribuição. De seguida foram realizados ensaios em células em cultura, usando 
a linha celular EL-4 derivada de linfoma, onde a disponibilidade de fosfato no meio de cultura 
variava usando as concentrações 0.32 mM, 3 mM, 6 mM, 9 mM e 18 mM. A partir destes 
ensaios foram estimados o número de células, o uptake de fosfato e a expressão de genes em 
cada uma das condições de fosfato previamente referidas. Estes ensaios de variabilidade de 
fosfato também foram realizados em células wild-type e células leucémicas de timo de ratinho. 
De uma forma geral, foi confirmada a presença de um maior número de células em timos 
leucémicos quando comparado com timos wild-type. Ensaios de variabilidade de fosfato 
sugeriram que a proliferação celular mostra ser reduzida nas condições de fosfato abaixo ou 
acima do controlo positivo (6mM), apesar dos valores normais no organismo rondarem entre 
1.5 e 3 mM. Esta debilitada proliferação também relacionada com o tempo a que as células 
expostas a estas diferentes concentrações de fosfato, porque quanto mais tempo está na presença 
das diferentes condições, menor é a proliferação celular.  
Foi também verificado que o estado de homeostasia presente no interior da célula deve-
se apenas à quantidade de fosfato presente no meio extracelular, porque quanto maior é essa 
quantidade presente no meio, maior é o seu uptake. Por fim, a expressão de PiT-1 e PiT-2 não 
mostraram variações significativas com as diferentes condições de fosfato, não indicando o seu 
envolvimento na proliferação celular. Curiosamente, XPR1 mostrou a possibilidade de estar 
envolvido no exporte de fosfato, tendo os seus valores de expressão igualado os dos 
transportadores PiT-1 e PiT-2. α-klotho exibiu uma possível função como agente anti 
envelhecimento pois apresentou uma expressão mais elevada em células em estado quiescente 
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do que em células em estado proliferativo. As diferenças de expressão destes mesmos genes 
não mostrou variação em tecidos wild-type e leucémicos. 
 
Palavras-chave: fosfato, cotransportadores SLC20, proliferação celular, timo e 
leucemia. 
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1. Introduction 
 Phosphate in physiological systems 
Phosphorus is an essential mineral found in all human tissues1,2 which plays important 
roles in many physiological processes, and because of this is very important to maintain its 
homeostasis. Inorganic phosphorus is usually associated with oxygen in the form of phosphate 
anion (PO4
3-) that exists predominantly in two forms, the monovalent form H2PO4
-
 and the 
divalent form HPO4
2-, being that the last embodies 80% of total at a physiological pH of 7.4.3,4 
Phosphate is involved in structural, metabolic and regulatory processes in every cell. Pi 
provides the high energy bonds in ATP, is part of nucleic acids and proteins, being therefore 
incorporated in the DNA structure, in cell membrane phospholipids and in phosphoproteins 
necessary for mitochondrial function. Phosphate is also important for cellular metabolism, 
cellular growth, signaling pathways, enzymatic activities via kinase and phosphatase mediated 
processes and maintenance of acid–base balance.4–7  
Its distribution is approximately 85% in skeletal tissues complexed with calcium in the 
form of hydroxyapatite, nearly 15% in soft tissues within cells, and the remainder (less than 
1%) spread in the extracellular fluids as inorganic Pi.4,8–10 It is essential that the extracellular 
concentration of Pi is maintained at a constant narrow range between 0.8 and 1.5 mM (in 
humans) for proper cellular function.4,11 
In humans, phosphate equilibrium is achieved by balancing Pi intake through absorption 
in the small intestine, exchange with intracellular and body storage pools, Pi excretion in urine, 
and renal tubular Pi reabsorption in the kidney. The amount of phosphate absorbed across the 
small intestine is approximately 950 mg/day (Figure 1.1) and represents about 80% of the 
dietary phosphate. The unbound phosphate existent in the plasma (extracellular pool) is freely 
filtered by glomeruli and then approximately 90% is reabsorbed in the proximal tubules. In a 
balanced state, the amount of Pi excreted in urine is almost the same as the Pi absorbed in the 
small intestine (Figure 1.1).1,2,12,13 
The movement of Pi into the cell occurs mainly through a process of regulated active 
transport across the cell membrane, mediated by two solute carrier families of transporters: 
SLC20 and SLC34 (section 1.2).4,5,7 These carry both Pi and Na+, and the transport is partially 
created by the electronegative charge existent in cell interior relative to the exterior as 
17 
 
consequence of leak in the potassium cation (K+) channel, which maintains a voltage difference 
across the cell membrane.14 
 
 
Figure 1.1 – Phosphate homeostasis in humans. The small intestine and kidney play the major roles in 
phosphate (Pi) homeostasis by regulating absorption and excretion, respectively. In states of neutral Pi balance, 
most part of Pi absorbed in the small intestine is excreted in urine. The movement of Pi into bone and soft tissues 
also determines serum Pi concentrations. Exit from extracellular Pi pool into bone formation is roughly equal 
to entry into the extracellular Pi pool due to bone reabsorption. The same equilibrium process occurs between 
extracellular and intracellular Pi pool. Adapted from 1,2,12,13 
 
 
Concentrations of intracellular phosphate are influenced by pH, hormones, vitamins and 
subcellular compartmentalization, where the levels in compartments such as mitochondria, 
lysosomes and endoplasmic reticulum are regulated by separate transporters. The most 
important regulating hormones are parathyroid hormone (PTH) and FGF23 (fibroblast growth 
factor 23), and other factors, such as the growth hormone (GH), thyroid hormone (TH) and 
dopamine, play a secondary regulatory role. These hormones are also denominated 
18 
 
calciophosphotropic hormones because they are dedicated to the regulation of both phosphate 
and calcium, since the balanced concentrations of these ions are interdependent. Not only is the 
active form of vitamin D (1,25-dihydroxyvitamin D3) important for Pi regulation but also 
metabolic factors and other circulating proteins, which contribute to Pi homeostasis according 
to the organisms necessities.1,2,5,7,9,15 
Given the importance of Pi homeostasis, its widespread distribution and critical role in 
cellular processes it is predictable that its defiance results in severe pathologies. Intracellular 
phosphate levels are elevated in pathological conditions such as ischemia, hypoxia, skeletal 
muscle fatigue, and some inherited disorders such as mitochondrial myopathies. 
Hyperphosphatemia is a common and serious complication of chronic renal failure (CRF), 
contributing to secondary hyperparathyroidism, tissue calcifications and metabolic changes. 
Gene mutation can be one of hyperphosphatemia causes as it is also tumoral calcinosis. 
Conversely, decreased intracellular levels of phosphate are observed in clinical disorders with 
severe hypophosphatemia and may be caused by malnutrition, malabsorption, or inherited 
disorders affecting renal phosphate reabsorption such as hypophosphatemic rickets and X-
linked hypophosphatemia. Prolonged phosphate deficiency is associated with disruption of both 
the metabolic and mineralization functions of phosphate leading to osteomalacia, risk of 
nephrolithiasis, hemolysis, neuropathy, respiratory failure from muscle weakness, and reduced 
myocardial contractility.1,15–17 
 
 
 Phosphate transporters 
Phosphate absorption across the plasma membrane occurs against an electrochemical 
potential difference, which accumulate phosphate at concentrations larger than would be 
predicted if phosphate were distributed passively across the membrane. This active process 
involves the transfer of a phosphate anion from the lumen to cytosol against concentration 
gradient and therefore can be defined as an active transepithelial transport. Pi import is mediated 
by secondary-active-Na+-dependents cotransporters, which rely on a high extracellular sodium 
gradient, that is maintained by the membrane associated Na+/K+ ATPase (Figure 1.2).18 This 
cotransporters are located in the apical membrane of the cell and the identity of proteins 
responsible for the basolateral Pi efflux is still unknown, although recently studies with a 
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membrane molecule XPR1 may show otherwise.6 There are two families of solute carriers 
mainly responsible for the co-transport, which are the SLC34 and SLC20 families (see 
below).4,5,18,19 These two families are non-related in their phylogeny and the transporters differ 
in their amino acid sequence, affinity for phosphate and mechanism controlling their activity 
and tissue expression.7 A third cotransporter family, SLC17, is sometimes referred to as type I 
Na+-dependent Pi transporter family, but studies using a cloned member of this family in 
Xenopus laevis oocyte showed a low specificity for Pi transport and rather more for transport 
organic anions, such as glutamate.20 
 
 
Figure 1.2 – Phosphate transport. Distribution and localization of phosphate transport proteins at the 
enterocytes in small intestine (A) and at the proximal tubule cells in kidney (B). Pi transport is mediated by 
Na+-dependents cotransporters localized in the BBM (apical membrane); (A) NaPi-IIb is responsible for Pi 
absorption (divalent form,HPO4
2−) in enterocytes and (B) NaPi-IIa, NaPi-IIc (divalent form,HPO4
2−) and PiT-
1/2 (monovalent form,H2PO4
−) are responsible for Pi reabsorption in proximal tubule cells. In both cases this 
Na+-dependent co-transport is reliant on Na+/k+ ATPase, localized at the basolateral membrane, that conserves 
a high extracellular sodium gradient. The basolateral Pi exit pathway remains unknown. Adapted from 4,5,21 
 
 
1.2.1 SLC34 family 
The SLC34 family, referred as a type II Na+/Pi cotransporter family, includes the three 
proteins SLC34A1 (NaPi-IIa), SLC34A2 (NaPi-IIb) and SLC34A3 (NaPi-IIc). NaPi-IIa and 
NaPi-IIc are responsible for Pi reabsorption in the brush border membrane (BBM), a epithelial 
layer covered with microvilli, of the renal proximal tubules, while NaPi-IIb has broader pattern 
of expression and it highly abundant in the enterocytes of the small intestine.4,5,18,22 
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All the SLC34 proteins preferentially transport divalent Pi (HPO4
2-) and require Na+ 
ions to co-transport Pi, although in a few cases Li+ ions can also partly replace Na+ to drive the 
transport.23 Both NaPi-IIa and NaPi-IIb are electrogenic and transport divalent Pi, with a strict 
Na+:Pi stoichiometry of 3:1. NaPi-IIc is electroneutral and exhibits a 2:1 stoichiometry.24 The 
apparent affinity of this transport system for phosphate is 100 µM at 40 mM sodium and pH 
7.4.4 This transport capacity is strongly pH dependent because protons directly modulate the 
transport kinetics and because pH defines the divalent-monovalent Pi ratio in the lumen, where 
the acid dissociation constant (pKa) is pH 6,8 in which divalent form (HPO4
2-) turns into 
monovalent form (H2PO4
-)25 Early in vitro characterization of this transport used brush-border 
membrane vesicles (BBMV) from renal and intestinal epithelial tissue26 and further ones used 
both cloned transporters in Xenopus laevis oocytes to characterize the regulation of the 
transport.27 These proteins are the most broadly characterized in terms of function, structure and 
regulation.22 
 
 
Figure 1.3 – Mechanism and molecular features of SLC32 family. The basic transport cycle is shown in the 
left panel and the salient molecular features is shown in the right panel. For the SLC34 proteins, the 
transmembrane protein is inwardly related with Na+ gradient and comprises an ordered sequence of binding 
steps (indicated by the numbers) in which two Na+ ions (1 and 2) bind sequentially, followed by binding of 
divalent Pi (3) and of a third Na+ ion (4). Substrate release to the cytosol occurs after reorientation of the fully 
loaded carrier. For electrogenic NaPi-IIa/b, an intrinsic negative charge (AAD, aspartic acid) confers voltage 
dependence to the transport cycle, allowing the binding of the first Na+ ion and subsequent translocation together 
with the other substrates, giving the 3:1 Na+:Pi stoichiometry. After all substrates are released to the cytosol, 
the intrinsic charge again senses the transmembrane field, leading to a voltage-dependent reorientation of the 
empty carrier. For electroneutral NaPi-IIc, a conserved glycine (SSG) binds one Na+ ion, like NaPi-IIa/b, but 
this ion is not translocated, giving a 2:1 Na+:Pi stoichiometry. Topology model for SLC34 show the predicted 
transmembrane domains (numbered 1-12) and repeated regions (dark blue). Disulfide bridge, glycosylation sites 
and critical residues for targeting, regulation, and electrogenicity are highlighted in the right panel. Image 
adapted from 4,5. 
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1.2.2 SLC20 family 
The SLC20 family, referred as a type III Na+/Pi cotransporter family is the most recently 
described one and comprises the proteins SLC20A1 (PiT-1) and SLC20A2 (PiT-2), which are 
responsible for the transport of the monovalent Pi (H2PO4
-) with a strict Na+:Pi stoichiometry 
of 2:1.4,5 
This Na+/Pi cotransporter family was originally identified as retroviral receptors for 
gibbon ape leukemia virus (Glrv-1)28 and rat amphotropic virus (Ram-1), a function that was 
not found in humans.29 Later to this discover, both receptors were found to mediate phosphate 
transport in a Na+-dependent manner after the expression in Xenopus laevis oocytes, although 
the kinetic characterization was very limited. Giving this newly characteristics of the retroviral 
receptors, Glvr-1 and Ram-1, were renamed PiT-1 (phosphate transporter 1) and PiT-2 
(phosphate transporter 2), respectively.30 
Their widespread expression pattern in all tissues gives them the designation of 
housekeeping role although more specific physiological roles are emerging for these 
transporters.4,5,18,23,31 For example, PiT-1 might play an important role in bone Pi homeostasis 
and its abundance is regulated by several factors involved in bone metabolism, including BMP2 
and IGF-1.32 Additionally, a number of studies also suggest a role of PiT-1 in 
hyperphosphatemia induced calcification of blood vessels33, as well as in parathyroid 
function.34 Recently a new function of PiT-1, independent of its transport function, has 
emerged. Depletion of PiT-1 expression in HeLa cells resulted in reduced cell proliferation and 
impaired mitosis.35 In vivo studies accentuated these findings by showing that a PiT-1 knockout 
mouse is embryonically lethal, reflecting its importance in liver development36, anemia and 
arrested growth.37 
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Figure 1.4 – Mechanism and molecular features of SLC20 family. The basic transport cycle is shown in the 
left panel and the salient molecular features is shown in the right panel. For SLC20 proteins, the transport 
sequence comprises an initial binding of one Na+ ion (1), followed by a random interaction of monovalent Pi 
and a second Na+ ion (2 and 3). Reorientation of the loaded carrier then leads to substrate release in the cytosol. 
Topology model for SLC20 show the predicted transmembrane domains (numbered 1-12) and repeated regions 
(dark blue). Glycosylation sites are highlighted in the right panel. Image adapted from 4,5. 
 
 
 Phosphate efflux across the basolateral membrane 
As described above, phosphate homeostasis in multicellular eukaryotes is dependent on 
transcellular Pi transport in different tissues and organs, which includes not only controlled Pi 
influx, but also efflux out of cells. In metazoans, efflux of Pi is an obligatory step at the 
basolateral side of the kidney proximal tubule and small intestine epithelial cells for Pi transfer 
to the blood stream. Despite the importance of Pi efflux to its homeostasis, very little is known 
about its control and the transporters involved in this process.38 
In mammals, XPR1, a membrane protein initially identified as the cell surface receptor 
for xenotropic and polytropic murine leukemia retroviruses (X- and P-MLV) has been studied 
as a possible phosphate exporter given the fact that this protein is homologous with PHO1, 
responsible for Pi efflux in plants, such as Arabidopsis thaliana.6,38 PHO1 was the first protein 
to be identified as a Pi export mediator in eukaryotes.39   
This XPR1 protein reveals a very broad expression pattern in tissues as diverse as 
kidney, brain, skin, liver, heart and lung,38 and interestingly, phosphate efflux has also been 
reported in an extensive range of cells such as pancreatic B cells, hepatocytes, jejunal 
enterocytes and cells of the renal proximal tubules.40,41  There are some studies indicating that 
both XPR1 depletion and blocking with XRBD (X-MLV Env-derived ligand)  induced a 
decrease in Pi export and that reintroduction of various XPR1 proteins, from fruit fly to human, 
restored this deficiency.6 Altogether, these data suggest that although alternative pathways for 
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phosphate export may exist, the severity of its inhibition indicate that XPR1 has an important 
physiological role in controlling phosphate.38 
 
 
 Regulation of phosphate absorption and/or reabsorption 
Body phosphate homeostasis is largely dependent by modulation of intestinal absorption 
of dietary phosphate, renal phosphate reabsorption and excretion, and the exchange of 
phosphate between extracellular and bone storage pools.2 Serum levels are regulated by a 
combination of local and humoral factors. The majority of this humoral factors are 
calciophosphotropic hormones including parathyroid hormone (PTH), fibroblast growth factor 
23 (FGF23), active vitamin D (1,25-dihydroxyvitamin D3), among others factors, that are 
maintained by several negative feedback loops.42,43 
 
1.4.1 Small intestine 
As described previously, the phosphate absorption is executed in the small intestine and 
its Na+-dependent transport in the brush border membrane of enterocytes is mediated by NaPi-
IIb (Figure 1.5) and it provides the rate-limiting step for the transcellular uptake of Pi44,45. 
Studies using NaPi-IIb knockout mice have shown that absence of this intestinal brush border 
membrane transporter triggers compensatory renal mechanisms where, NaPi-2a is upregulated, 
to maintain phosphate homeostasis46 suggesting that phosphate balance is mediated at a central 
level. 
There has also been interest in the potential role of PiT-1 and PiT-2 in intestinal 
phosphate transport. A recent study revealed that PiT-1 mRNA is present throughout the small 
intestine, while the mRNA levels of PiT-2 are low. Both these proteins may contribute only 
moderate (approximately 5%) to transepithelial Pi transport in small intestine.5,45 
Dietary phosphate and vitamin D are thought to be the most important physiological 
regulators of intestinal Pi absorption.47 Vitamin D will enhance NaPi-IIb expression as 
described in Figure 1.5. There are other factors as glucocorticoids,48 estrogens and metabolic 
acidosis49 that can also affect intestinal absorption.  
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1.4.1 Kidney 
Following absorption in the small intestine, Pi reabsorption in the kidney is the next, 
and most well-known step, to maintain Pi homeostasis. The Na+ -dependent phosphate transport 
in the brush border membrane of proximal tubule is mediated by NaPi-IIa and NaPi-IIc, which 
act as the rate-limiting step for phosphate reabsorption of filtered phosphate from urine.  
Interestingly, even though double knockout mice for NaPi-IIa and NaPi-IIc presented 
severe hypophosphatemia and increased phosphaturia, there is still residual renal phosphate 
reabsorption which indicates that there are others transporters able to maintain some Pi 
reabsorption. In this situation, PiT-1 and PiT-2 mRNAs were detected in the kidney, but only 
PiT-2 occurred as protein.16 As in small intestine, PiT-1 and PiT-2 appear to only contribute 
with 5% to transepithelial transport in kidney in normal conditions.5 
Renal Pi reabsorption is regulated by dietary Pi intake and several hormones, such as 
PTH, vitamin D and FGF23, that can directly or indirectly control Pi balance (Figure 1.5).50 In 
addition there are other minor hormones that also affect renal Pi handling for example growth 
hormone, insulin and thyroid hormone can increase phosphate reabsorption, whereas calcitonin 
and glucocorticoids can decrease it.3 PTH is the most powerful phosphaturic hormone,51 and its 
production is enhanced by high circulating phosphate levels42, suppressing Pi reabsorption by 
inducing NaPi-IIa internalization and subsequent lysosomal degradation (Figure 1.5).52  
FGF23 is a bone derived phosphaturic hormone secreted by osteocytes and osteoblasts53 
and its effects are mediated by binding to FGF receptors (namely FGFR-1) and co-receptor α-
klotho.54,55 FGF23 is a circulating hormone and its signaling inhibits renal Pi reabsorption by 
suppressing the expression of NaPi-2a cotransporter and Pi absorption by inhibiting PTH 
activity and vitamin D synthesis.3,56 
α-Klotho is a newly identified membrane protein, characterized as an anti-ageing gene 
and a tumor suppressor.57,58 Genetic mutation of klotho in mice causes premature aging-like 
phenotypes such as vascular calcifications and skin atrophy. Its overexpression suppresses 
aging and extends lifespan and at the same time that it may result in inhibited cancer cell 
proliferation.57,58 α-Klotho is predominantly expressed in renal distal tubules59 where it plays 
its main function as a co-receptor of FGFR regulating FGF23 signaling and so contributing to 
Pi homeostasis. It is also known that α-klotho can regulate Pi excretion independent from 
FGF23 as paracrine and endocrine mediator, when under the form of soluble klotho.55 Studies 
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in a α-klotho knockout mice and a FGF23 knockout mice indicate increased renal expression 
of the NaPi‑IIa protein and elevated serum levels of vitamin D, associated with 
hyperphosphatemia.60  
 
 
Figure 1.5 – Phosphate regulation. Phosphate is mostly regulated by dietary Pi intake, PTH, 1,25-
dihydroxyvitamin D3 (vitamin D active form) and FGF23, that can directly or indirectly control Pi balance. 
When Pi uptake is elevated, the extracellular Pi pool is increased, and to try normalize this hyperphosphatemia 
state, parathyroid glands are enhanced to secrete PTH that will act on the kidney and reduce Pi reabsorption 
mediated by cotransporter NaPi-IIa, and it will also reduce the synthesis of active vitamin D by inhibiting the 
enzyme that mediates this synthesis, 1α hydroxylase. As consequence, Pi absorption in the small intestine 
mediated by the cotransporter NaPi-IIb, is also reduced, given the fact that this is enhanced by vitamin D. In 
addition, Pi reabsorption in bone will also be inhibited. In cases of hypophosphatemia, the reverse of what was 
described above will occur. In this state, FGF23 production by osteocytes and osteoblasts in bone and 
consequent secretion will increase, which is also enhanced by active vitamin D up-regulation. FGF23 acts 
through one or more FGF receptors, with Klotho as co-receptor, to reduce renal phosphate re-absorption, to 
decrease circulating vitamin D levels. Adapted from 17,61. 
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1.4.2 Phosphate sensing mechanism 
A diversity of mechanisms have evolved to maintain phosphate homeostasis. In cases 
of phosphate deficiency, acquisition and retention of Pi by the organism should be accelerated, 
and contrariwise, in cases of Pi excess, acquisition and retention of Pi should be reduced. A 
necessary first step in Pi regulation is the ability of a cell or organism to sense changes in Pi 
concentrations in its environment and adjust its metabolic processes to accommodate such 
variations. Phosphate sensing in bacteria, such as Escherichia coli, and yeast, as Saccharomyces 
cerevisiae, appears to involve uptake of extracellular phosphate, activation of an intracellular 
sensor which leads to the transcription of phosphate-specific proteins. Based on these 
considerations it is possible that similar events are conserved in metazoan species including 
humans, however the exact molecular nature of these mechanisms is still unclear.1,17,23,62 
In Escherichia coli, when the phosphate specific transporter “detects” low Pi 
concentrations in the environment, the Pi retention will increase. This process is achieved by a 
sequence of phosphorylation reactions of a regulatory system that interacts with a “phosphate 
regulon”, a collection of genes under regulation by the same regulatory protein, being the 
predominant Pi uptake system. Bacteria express a second family of phosphate transporters, 
which are related to eukaryotic type III sodium-phosphate cotransporters (SLC20) but they 
serve primarily as a cotransporter of divalent metal cations associated with phosphate. 
Interestingly, PhoU, a protein integrated in the phosphorylation reactions described above, 
contains a domain similar to eukaryotic type II sodium-phosphate cotransporters (SLC34), but 
the significance of which is unclear.17 
In Saccharomyces cerevisiae, phosphate controls a specialized transcription factor 
called Pho4, and the reduced Pi concentrations in the external environment results in its 
inactivation by the complex Pho80-Pho85. The inactivated Pho4 will enter the nucleus and bind 
to Pho-regulon including genes for high affinity phosphate transporters (Pho84 e Pho89).63 This 
phosphate transporter Pho84 belongs to a large family, which includes the type I sodium-
phosphate transporters (SLC17) and Pho89 is related to both member of type III sodium-
phosphate transporters family (SLC20).17  
Additional studies of phosphate-sensing made by Markovich et al using kidney 
epithelial cells from opossum showed that they are able to respond to changes in environmental 
Pi concentrations by altering the efficiency of Na+-dependent Pi absorption in a short time, after 
2 h of cell culture.64 In addition it was shown that non-epithelial cells, such as osteoblastic, 
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fibroblastic and marrow stromal cell have a response to changes in environmental Pi 
concentrations by altering BMP-4 (bone morphogenic protein 4) expression, Runx2/Cbfa1 
(transcriptions factor regulators of bone formation) localization, alkaline phosphatase secretion 
and MAPK signaling pathway Pi activation dependency. Additionally, blocking PiT-1 co-
transport receptor showed an inactivation of  MAPK signaling pathway that in agreement with 
the previous data suggest a sensorial detection mechanism.1,17 
Phosphate regulation in animals have suggested that immediately following a meal 
containing Pi, rapid alterations in the renal excretion of phosphate occur that are not associated 
with changes in calciophosphotropic hormones, such as vitamin D and PTH, and other 
regulating factors. However, the feeding of animals with high Pi diets over a period of weeks 
shows changes in the regulatory factors, suggesting that this sensing detection mechanism may 
be related with the short-term response to alteration of phosphate concentration.62 Segawa et al 
have demonstrated an increase in NaPi-IIb expression in vitamin D receptor knockout mice65 
but in contrast, the amount of PiT-1 mRNA was increased and only decreased after 
administration of vitamin D34, strengthening the existence of a sensor within or in the surface 
of cells that is able to detect changes in the concentration of phosphate.  
There are only sparse examples in the literature of transporters or channels that have 
been shown to possess additional functions independently of their transport function. 
Additionally to the ones showed above, Human PiT2 has been shown to modify its 
oligomerization independently of Pi uptake in response to changes in the extracellular Pi 
concentration, suggesting a possible role of PiT2 in Pi sensing. However, it is not known 
whether PiT-2 (or PiT-1) has any direct signaling activity in response to Pi. A potential role of 
PiT proteins in Pi sensing maybe important for cellular functions, such as proliferation.66 
 
 
 Role of Pi in cell development and proliferation 
The SLC20 family includes two proteins PiT-1 and PiT-2 with a known function in 
phosphate transport, as described previously. Their broad tissue distribution has led to the 
proposal that these two cotransporters could perform a housekeeping role for cellular Pi 
homeostasis.4,31,67 In contrast with the SLC34 family of cotransporters, which have been 
extensively explored and characterized,11,68 the novel roles, in addition to Pi transport, of these 
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ubiquitously expressed SLC20 proteins only beginning to emerge.67 Given the combined role 
of phosphate in cellular processes and the function of PiT-1 and PiT-2 as ubiquitous suppliers 
of phosphate to the cell, it was not unexpected to uncover a new role for these transporters may 
have additional roles in bone metabolism69, parathyroid function34 and most importantly in cell 
proliferation and mitosis activity35,70 independent from the already known transport function. 
Bone is a major organ involved in Pi homeostasis and its storage, so Pi systemic control 
is indispensable for bone formation and mineralization.61 Yoshiko et al showed that a Na+/Pi 
cotransporter inhibitor blocked the mineralization of cultured osteoblasts, and the same was 
true for local mineralization in newborn rats skulls after injection. Gene expression of both PiT-
1 and PiT-2 decreases along osteoblast development, where PiT-1 expression is higher than 
PiT-2, but conversely the accumulation of respective proteins increases with development. This 
information coupled with the fact that these researchers showed a higher necessity of Pi in 
mature osteoblast suggests that both PiT-1 and PiT-2 may play a different roles in bone tissue.69 
High levels of phosphate are associated with hyperphosphatemia, and are also important 
in the development of hyperparathyroidism, which is characterized by an increase in 
parathyroid cells number and consequent PTH production. Currently there is no evidence that 
the uptake of extracellular Pi is necessary to exercise its effect on PTH. Moreover, Tatsumi et 
al showed that the Pi action may be mediated by PiT-1, not as a Na+/Pi cotransporter but as a 
cell surface Pi-sensing protein34 in bacteria and yeast.17 
Recent studies have shown that PiT-1 depletion repressed cell proliferation in HeLa 
cells35 and that PiT-1 knock-out mice did not survive past day 12.5 of development (E12.5)36. 
In HeLa cells it was observed that PiT-2 overexpression partially recovered the defective PiT-
1 transporter function, and Pi uptake reached almost normal levels, but did not rescued the cell 
proliferation defects. These findings are consistent with the knock-out mice results where E11.5 
embryos with PiT-1 mRNA levels below 15%, comparing to the wild-type (WT), showed an 
up-regulated PiT-2 expression, indicating that compensatory elevated PiT-2 expression is 
essential for survival of PiT-1-deficient cells. It is also important to highlight that PiT-1 knock-
out mice at E11.5 showed a reduced proliferation of developing hepatocytes and subsequent 
reduced hematopoiesis. Given the fact that Pi uptake was not altered significantly in any of the 
previous cases and that cell proliferation was not rescued by PiT-2 indicates that the transport 
function of PiT proteins is independent from this newly hypothesized function as cell 
proliferation regulators.35 Differences in function/recovery in rescued systems may also be 
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explained by the only 75% homology between this two proteins. PiT-1 has a intracellular loop 
not shared with PiT-2 and other members of the SLC20 family in plants and bacteria.71 
It was also described that over-expression of PiT-1 can increase the proliferation and 
the culture densities of two cell lines, MC3T3-E1 and NIH3T3. These cell lines exhibit strictly 
density-inhibited cell proliferation, indicating that PiT-1 not only is involved in cell 
proliferation but can also regulate cell density and anchorage-independent growth.70 
On the steps of this published data showing that SLC20 family proteins, especially PiT-
1, are involved in proliferative and development cellular processes, this project will take 
advantage of the highly proliferative thymus to further try to understand these mechanisms, 
using tumorigenic cell lines and isolated cells from normal and abnormal tissue, namely from 
thymic lymphoma cells.  
The thymus is a small organ composed by two lobes located in the thoracic cage just 
behind the sternum. The thymus is an important part of the body’s immune system and is 
involved in the production and maturation of T lymphocytes. T lymphocytes develop in the 
thymus (Figure 1.6) and then exit, through the blood circulation, colonizing different tissues 
including secondary lymphoid organs (e.g. spleen and lymph nodes) and the bone marrow, 
where they will exert their immune function. There they help the immune system to protect the 
body from viruses, fungus, other types of infections, and malignantly transformed cells.72,73 As 
the thymus is composed of different cell types, each can develop into different types of cancer. 
Epithelial cells originate thymomas and thymic carcinomas, while neuroendocrine cells 
originate carcinoid tumors and lymphocytes lymphomas.74 
Tumorigenic cells are well known for sustaining proliferative signaling, abnormal cell 
growth, resisting cell death, enabling replicative immortality and enhanced proliferative rate75 
which are the ideal characteristics to evaluate the role of phosphate and transporters in cell 
development and proliferation. 
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Figure 1.6 – T cell maturation diagram. T cells precursors from the bone marrow enter the thymus through 
the blood circulation to undergo further maturation. In an early stage, inside the thymus, they are double 
negative for CD4 and CD8 (membrane glycoproteins that act as cluster of differentiation) until MHC proteins 
(major histocompatibility complex) enhance a negative or positive selection, and maturation towards either 
CD4 or CD8 single-positive T cells. T helper cells are single positive for CD4 and T cytotoxic cells are single 
positive for CD8. Important to notice that leukemic cells in lymphoblastic lymphomas also express CD8 
proteins. Upon maturation they then leave the thymus to enter blood circulation and consequently other tissues, 
such as secondary lymphoid tissues. Adapted from 72,73. 
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 Objectives 
Phosphorus an essential mineral found in all human tissues and is involved in structural, 
metabolic and regulatory purposes in every cell such as cellular metabolism, cellular growth 
and signaling pathways. Pi homeostasis is maintained through transepithelial transport that is 
secured by SLC34 and SLC20 family in the apical membrane and possibly by XPR1 in 
basolateral side of the cell. Novel functions have been suggested for the SLC20 family, 
regarding cell proliferation and Pi-sensing, that may be relevant for the control of pathological 
conditions. Thus it is important to better understand its function in the organism the relations 
with associated proteins.  
The objective of the present study was to evaluate the role of extracellular phosphate in 
cell proliferation and the involvement of SLC20 members during this process. Consequently, 
tissue localization and expression levels of cotransporters PiT-1 and PiT-2, and related genes 
in mouse model were characterized in an attempt to establish its functional roles and 
involvement in normal and abnormal cell development and proliferation. To this end were used 
a lymphoblastic derived cell line (EL4), and wild-type and leukemic thymic cells removed from 
mice. To accomplish these goals, a methodology involving cell culture, mouse breeding and 
sampling, molecular biology and 33Pi transport assays was followed. 
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2. Methodology 
 Cell culture 
The EL-4 cell line was used for in vitro experiments. This cell line was established from 
a mouse thymic lymphoma, and therefore belongs to the T cell lineages. 
The EL-4 cell line was culture in suspension in RPMI 1640 (LONZA) cell culture 
medium supplemented with 10% fetal bovine serum (FBS, Biowest), 1% 
Penicillin/Streptomycin (LONZA) and 1% Glutamine (Sigma-Aldrich). Subcultures were 
maintained within a concentration of 2-20x106 cells/ml in T-25 or T-75 flasks, according to the 
experimental needs, in an incubator (Heracell™ 150, Thermo-Scientific) at 37ºC in a 
humidified 5% CO2 atmosphere. The cell culture medium was renewed every 2 to 3 days by 
adding or replacing with fresh medium, depending on the cell culture density and medium 
saturation. 
 
2.1.1 Proliferation assay in serum starvation 
Cells were seeded in 100 mm diameter Petri dishes in triplicate at a concentration of 
2,5x105 cells/ml in RPMI 1640 standard growth medium with two different FBS 
concentrations: 0.1% and 10%. At 24h, 48h and 72h time-points, the cells were resuspended 
and an aliquot of each condition and replicate was diluted 1:1 in Trypan Blue solution 0.4% 
(Sigma-Aldrich) and counted using Neubauer counting chamber (MARIENFELD). At the 48h 
time-point cells from both conditions were centrifuged (Eppendorf) at 500g for 5 minutes and 
resuspended in RPMI 1640 standard growth medium with 10% FBS to evaluate cell recovery 
from a quiescent state. In every time-point, an aliquot of 1x106 cells was collected at each 
experimental replicate that were combined as a single sample, for posterior RNA extraction and 
molecular analysis. Every sample was stored in RNAlater as described below. All experiments 
were performed in triplicate. 
 
2.1.2 Proliferation assay in phosphate starvation 
Cells were seeded in 24-well plates at a concentration of 2.5x105 cells/ml in RPMI 1640 
without phosphate, with 0.85 g/l sodium bicarbonate (NaHCO3) supplemented with 10% FBS, 
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1% Pen Strep, 1% L-Glut and 13,69 mM/L NaHCO3, to match the RPMI 1640 standard growth 
medium pH values. 
Cells were cultured in different phosphate conditions where a different amount 
correspondent to these concentrations was added from a phosphate Sorensen buffer 0.5 M stock 
solution (annex 1): 0.32 mM (residual Pi concentration present in the cell culture medium); 3 
mM; 6 mM; 9 mM and 18 mM, for 96h, using as positive control cells cultured in RPMI 1640 
standard growth medium (≈ 6 mM PO4). At 24h, 48h, 72h and 96h time-points, the cells were 
resuspended and an aliquot of each condition and replicate was diluted 1:1 in Trypan Blue 
solution 0.4% (Sigma-Aldrich) and counted using Neubauer counting chamber (Marienfeld).In 
every time-point an aliquot of 1x106 cells was collected for every technical replicate at each 
experimental replicate that were combined as a single sample, for posterior RNA extraction and 
molecular analysis. Every sample was stored in RNAlater as described below. All experiments 
were performed in triplicate. 
 
2.1.3 Cell viability assay for cytotoxicity evaluation 
Cells were seeded in 96-well plates at a concentration of 1x104 cells/well in RPMI 1640 
without phosphate (described above), and cultured in different phosphate concentrations: 0.32 
mM; 3 mM; 6 mM; 9 mM and 18 mM for 48h and 96h, in separate plates, using as positive 
control cells cultured in RPMI 1640 standard growth medium (≈ 6 mM PO4). 
At the end of the assay, at 48h or 96h, 10 µl of MTT solution (5mg/mL in PBS) was 
added to each well and incubated at 37ºC for 4h. MTT (3-[4,5-dimethylthiazol-2-yl]2,5-
diphenyltetrazolium bromide) is a yellow substrate that is cleaved by living cells to produce a 
dark blue formazan product, a process that requires active mitochondria.76 At the end of the 
incubation 100 µl of DMSO (Dimethyl sulfoxide, Sigma-Aldrich) was added to dissolve the 
formazan to give a homogeneous blue solution suitable for absorbance measurement. After 1h 
of incubation, the absorbance was measured on a spectrophotometer plate reader (Infinite® M200, 
Tecan) at a wavelength of 570 nm. All experiments were performed in triplicate. 
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2.1.4 Phosphorus quantification assay 
The phosphorus quantification was determined by means of a phosphorus colorimetric 
assay (ref. 1001155, Spinreact) modified for microplates. Concentration was measured in 
samples collected at three time-points of cell culture: 0h, 48h and 96h, using the culture medium 
with different phosphate levels in the section 2.1.2. At 0h the samples were collected prior to 
phosphate addition to cells, and at 48h and 96h the samples were collected from the cell culture 
by centrifugation at 500g during 5 minutes. Briefly, a standard curve was prepared with a range 
of 0 mM to 7.5 mM from the Na2HPO4*NaH2PO4 (Sodium hydrogen phosphate* Sodium 
dihydrogen phosphate) stock solution provided in the assay Kit. Next, 2.5 µl of each standard 
point and the same volume from each sample were plated in a 96-well plate, with three technical 
replicates each. Then after incubation for 10 minutes at RT, the absorbance was measured on a 
spectrophotometer plate reader at a wavelength of 340 nm. 
 
2.1.5 Phosphate uptake assay with 33P 
Phosphate measurements were performed for cells that were submitted to the conditions 
described in section 2.1.1 and 2.1.2. For the serum starvation, 33P was measured in cells 
collected at two time-points of culture, 48h and 72h, while in the phosphate starvation 33P was 
measured at 96h.  
After the cultivation period cells were collected in 4 replicates of 1x106 cells each for 
every condition. Cells were then incubated with approximately 0.063 µl of the 33Pi radioisotope 
(specific activity: 5 µCi/µl) solution, diluted in RPMI 1640 culture medium in a total of 500-
1000 µl (standard for 2.1.1 and without phosphate for 2.1.2). A preliminary assay was carried 
out on both conditions to determine the kinetics of Pi uptake over time. Samples were collected 
at 0, 5, 15, 30 and 60 minutes after the incubation with the radiotracer. In all situations it was 
found that close to linear uptake (measured as decays per minute inside the cells as indicated 
below) occurred between 0 and 30 minutes, with a plateau period following from 15 to at least 
6 minutes (Figure 3.6A). 
Therefore the subsequent incubations were performed in two time-points, 5 and 30 
minutes, at 37ºC. After the incubation, cells were immediately centrifuged at 500g for 5 minutes 
at 4ºC and washed two times with respective cell culture medium without tracer. The 
precipitated cells were then resuspended in 300 µl PBS and pipetted to a scintillation vial. 
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Following the addition of liquid scintillation (3.5 ml) the beta radioactive energy emitted from 
inside the cells was determined as counts per minute (approximation to decays per minute) by 
counting each sample for 10 minutes in a Microplate Scintillation and Luminescence Counter 
(MicroBeta TriLux, PerkinElmer). All experiments were performed in triplicate. 
 
 
 Mouse breeding and sampling 
The wild-type mice used for tissue expression studies were from the inbred strain 
C57BL/6. For the remaining studies the TEL-JAK2 transgenic animals77 were also used. The 
C57BL/6 strain is the most well-known inbred mouse strain with the entire genome published, 
and has been widely used as a genetic background for congenic and mutant mice. The TEL-
JAK2 transgenic mice results from a chromosomal translocation initiated with the fusion 
of JAK2, a gene on chromosome 9p24 to TEL, a gene localized at 12p13 that will encode a 
chimeric protein, TEL-JAK2, that contributes to the development of acute lymphoblastic 
leukemia.77,78 
For tissue expression analysis two males and one female wild-types mice were randomly 
chosen. Mice were euthanized by carbon dioxide inhalation followed by cervical displacement, 
and then placed on a flat surface, sprayed with ethanol and dissected. Dissection was initiated 
with a small abdominal incision that was gradually increased until whole abdominal cavity was 
exposed, followed by the removal of the tissues of study.  
 
2.2.1 RNA expression studies 
The dissection and extraction material was cleaned with RNaZAP (Sigma; spray 
solution that destroys superficial RNases) to prevent RNA degradation, and a sample of each 
tissue (about 0.5 cm3 each) was stored in RNAlater (Sigma; solution that stabilizes and protects 
RNA at RT by rapidly penetrating the tissue). Samples were initially stores at 4ºC for 24 hours 
and then at -20ºC according to the manufacturer’s instructions until further processing. RNA 
extraction was performed with an E.Z.N.A. ® Total RNA Kit I (VWR) following the protocol 
described in the kit instructions as indicated in the sections below. 
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2.2.2 Cell collection and culture 
For the assays with variation of phosphate availability, a total of 6 animals, 3 wild-type 
and 3 leukemic, were sacrificed using the same method as previously described. Leukemic 
animals usually present slower locomotion movements as well as slower reaction to human 
handling due to general weakness. They also present overweight that are associated with the 
evident swelling of the thymus, spleen and lymph nodes. Upon dissection, these characteristics 
were observed and presence of leukemic cells was confirmed using cell surface fluorescent 
immunostaining for flow cytometry. 
The thymus was recovered and maintained in ice-cold PBS 1X until cell extraction. Cell 
extraction was performed using a cell strainer against which the tissue was disintegrated with a 
syringe piston. The strainer was washed with RPMI 1640 medium with β-mercaptoethanol in a 
dilution of 1:1000 (helps to preserve the cell membrane), the cells were recovered in a 50 ml 
conical tube and after adding Trypan Blue solution 0.4% (Sigma-Aldrich) diluted 1:1, counted 
in a Neubauer counting chamber (Marienfeld), for following molecular analysis, 
immunostaining and 33P uptake assay.  
 
2.2.3 Cell surface fluorescent immunostaining for flow cytometry 
After thymus recovery from sick mice, and to confirm the presence of leukemic cells, I 
used a technique of immunostaining where membrane cluster of differentiation proteins are 
recognized by specific fluorochrome-labeled monoclonal antibodies.   
Table 1 – Specific murine antibodies used in FACScalibur flow cytometry with fluorochromes PE (R-
phycoerythrin) and Cy5 (cyanine). 
 
Antigens Specie Primary antibody Fluorochrome 
Emission spectra 
(nm) 
Dilution 
Anti-CD4 Murine Rat IgG2b, k PE 578 1/400 
Anti-CD8 Murine Rat IgG2a, k PE/Cy5 667 1/800 
 
For cell surface immunostaining assay, I used 1x106 cells for each sample. For the two 
thymic cell types (WT and leukemic) one tube was prepared without antibodies, one tube with 
each antibody, to assess overlap of emission spectra in the flow cytometer, and one with the 
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two antibodies (see Table 1). To each tube 1 ml of cold PBS/3%FBS/10 mM NaN3 was added 
and then centrifuged at 300g for 5 minutes at 4ºC. After discarding the supernatant, the pellet 
was resuspended in PBS/3%FBS/10 mM NaN3 with each antibody in a final volume of 50 µl 
for 1h on ice in the dark. To stop the incubation, 1 ml of PBS/3%FBS/10 mM NaN3 was added 
and centrifuged at 300g for 5 minutes at 4ºC. This step was repeated and the cells finally 
resuspended in 1 ml of PBS/10 mM NaN3 before analysis in a FACSCalibur (Becton 
Dickinson) flow cytometer. A total of 10 000 events were acquired and analyzed using the 
CellQuest software (Becton Dickinson). 
 
2.2.4 Phosphate uptake measurement assay with 33P 
Phosphate uptake measurements were performed in T cells right after tissue and cell 
recovery. Preceding the assay uptake, the cells were maintained at 37ºC for 1h in two 
conditions: RPMI 1640 medium with or without phosphate. For each condition 4 replicates of 
1x106 cells were collected. Cells were then incubated with approximately 0.063 µl of the 33Pi 
radioisotope (specific activity: 5 µCi/µl) solution, diluted in the correspondent RPMI 1640 
culture medium as described above. This incubation was performed in two time-points, 5 and 
30 minutes, at 37ºC. After incubation, cells were immediately centrifuged at 500g for 5 minutes 
at 4ºC and the culture medium in the supernatant removed. Cells were resuspended and the 
procedure repeated to wash the cells twice in cell culture medium without radioisotope. As 
described above, after the last wash cells were resuspended, transferred to scintillation vials and 
upon the addition of scintillation cocktail (ref. 1200-434; PerkinElmer), the radioactivity of 
each sample was measured for 10 minutes in a Microplate Scintillation and Luminescence 
Counter (MicroBeta TriLux, PerkinElmer). Liquid scintillation is a chemical that incorporates 
the radiolabeled compound allowing a uniform distribution and capable of converting the 
kinetic energy of nuclear emissions into light energy. All experiments were performed in 
triplicate. 
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 Molecular Analyses 
To evaluate expression of the phosphate transporter and associated genes mRNA was 
isolated and then complementary DNA (cDNA) synthetized and at last a polymerase chain 
reaction (PCR) or real time polymerase chain reaction (RT-PCR) was performed using specific 
primers. 
 
2.3.1 RNA extraction and quantification 
RNA extraction was performed using the Total RNA Kit I (VWR) for tissues and TRI 
Reagent for cell pellets.  
Extraction of RNA with E.Z.N.A. ® Total RNA Kit I (Omega, VWR) was performed 
following the provided protocol. First the amount of sample that would be used for the 
extraction was determined. Then TRK Lysis Buffer with β-mercaptoethanol 14.3 M was added 
to the sample to disintegrate the cellular membrane. This mixture was homogenized, 
centrifuged at 13200g for 10 minutes and the obtained supernatant was transferred to a new 
microtube. Next, 70% ethanol was added to the supernatant and mixed by repeated tube 
inversion to precipitate the RNA. This solution was transferred to a HiBind RNA column in a 
collection tube and then centrifuged at 10000g for 1 minutes at RT. The supernatant was 
discarded and then RNA Wash Buffer I was added to the column and centrifuged at 10000g for 
1 minutes at RT, following the same steps with RNA Wash Buffer II (with previously added 
absolute ethanol). RNA was eluted by adding DEPC (diethylpyrocarbonate) water (see annex 
1) in the column and centrifuging at 13200g for 2 minutes. RNA was stored at -20ºC. DEPC 
treated water is used to inactivate RNase enzymes by the covalent modification of histidine, 
lysine, cysteine, and tyrosine residues. 
Extraction of RNA with TRI Reagent (Sigma-Aldrich) was prepared following the 
provided protocol. First, 1 mL of TRI Reagent was added to the cell pellet, then gently vortexed 
and incubated for 5 minutes at RT. Next it 200 µl of chloroform were added to precipitate the 
RNA, incubated for 5 minutes at RT, mixing occasionally, and then centrifuged at 12000g for 
10 minutes at 4ºC. The supernatant was transferred to a new eppendorf tube, 500 µl of 
isopropanol were added and incubated for 5 minutes at RT. Then centrifuged at 12000g for 10 
minutes at 4ºC, and the supernatant was discard. Next 1 ml of 75% ethanol was added, and the 
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solution was vortexed and centrifuged at 7500g for 5 minutes at 4ºC. Finally, the supernatant 
was discarded, the pellet was air-dried for 10 to 15 minutes and resuspended in DEPC water. 
The RNA was quantified using the NanoDrop spectrophotometer (Thermo Scientific 
NanoDrop™ 1000) and this measurement includes the absorbance of all molecules in the 
sample that absorb at the wavelength of interest. Since nucleotides absorb at 260 nm, and 
protein, phenol or other contaminants absorb strongly at or near 280 nm, the resultant 260:280 
ratio will assure the purity of the sample. It is generally accepted that ratios of 1.8 for DNA and 
2.0 for RNA, and the actual ratio will depend on the composition of the nucleic acid. RNA have 
a higher 260/280 ratio due to the higher ratio of Uracil compared to that of Thyminutese.79 
Finally, RNA integrity was verified by running samples by electrophoresis in a 1% 
TAE-agarose gel with Ethidium bromide (0.1 %) and analyzing it in under UV light. 
 
2.3.2 Removal of genomic DNA contamination 
After RNA extraction, genomic DNA (gDNA) contamination is removed before cDNA 
synthesis and RT-PCR. To this end, samples were treated with DNase enzyme, from the DNA-
free Kit (Ambion). 
DNase treatment was performed using 10 µg of RNA to which 5 µl of DNase I 10x 
buffer, 1 µl of rDNase I (2U/ µl) and nuclease-free water, were added, to obtain 50 µl of reaction 
solution. The solution was homogenized gently and incubated at 37ºC for 30 minutes. After 
this, 5 µl of inactivation reagent were added to the mixture, vortexed for 1 minutes and 
incubated for 2 minutes at RT, mixing occasionally. The mixture was centrifuged for 1.5 
minutes at 10000g (room temperature). At the end the supernatant containing the RNA was 
recovered. 
The RNA was again quantified using the NanoDrop spectrophotometer (Thermo 
Scientific NanoDrop™ 1000). 
 
2.3.3 Complementary DNA (cDNA) synthesis 
Complementary DNA (cDNA) is synthetized from mRNA by the transcriptase reverse 
enzyme. Unlike gDNA it does not contain introns. 
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The synthesis of cDNA was carried out in a Thermal cycler (T100TM, Bio-Rad) using 
500 ng of DNase-treated RNA in which 1 µl of 10 µM deoxynucleotide-triphosphates (dNTPs), 
1 µl of 100 mM random hexamers (short oligodeoxyribonucleotides of random sequences that 
anneal to random complementary sites on the target mRNA, to serve as primers for cDNA 
synthesis), 4 µl of 5x reaction buffer and DEPC water were added in a final volume of 19.3 µl. 
This mix was heated in the thermocycler to 65ºC for 5 minutes and then cooled at 4ºC for 5 
minutes. Lastly 0.2 µl of Ribolock, RNase inhibitor (40 U/µl; Thermo Scientific), and 0.5 µl of 
RevertAid (200 U/µL; Thermo Scientific), reverse transcriptase, were added in a final volume 
of 20 µl. The samples were run in a synthesis reaction in the thermal cycler for 10 minutes at 
25ºC, 60 minutes at 42ºC and 10 minutes at 70ºC. The cDNA was stored at -20ᵒC and dilutions 
in nuclease free water were prepared as needed. 
 
2.3.4 Agarose gel DNA band purification 
The purification of TAE-agarose gel is a way to recover DNA products for downstream 
applications including cloning and sequencing. In this study TAE-agarose gel DNA band 
purification was necessary for sequencing target DNA products amplified by RT-PCR (section 
2.3.5.3) and by this way verify the primers specificity (section 2.3.5.1) and further prepare a 
standard curve (section 2.3.5.4) for every gene of interest. 
The band purification was performed with GFX PCR DNA and Gel Band Purification 
Kit following the provided protocol. After the assembly of the band of interest, a capture buffer 
was added, mixed and stored at 60ºC for 30 minutes. After this, the obtained solution is putted 
through a column and centrifuged at 16000g for 30 sec. Then 500 µl of wash buffer was added 
to the column and centrifuged again at 16000g for 30 sec. At the end, DNA was collected by 
adding 20 µl of elution buffer in the column and centrifuged at 16000g for 1 minutes. The eluted 
DNA was -20ºC. 
 
2.3.5 Polymerase chain reaction 
PCR is a procedure where DNA is amplified in vitro with a three-step cycling process: 
denaturation, annealing and extension.  
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The first step is the thermal denaturation of a DNA sample by raising the temperature 
to 95ºC. The second step is the annealing, where primers, synthetic oligonucleotides, base pair 
with their complementary sequence in the DNA template. In this step, the temperature is slowly 
cooled to approximately 55ºC, (depending on the primers sequence). In the third step occurs 
the synthesis of the target DNA, which is mediated by the Taq DNA polymerase, an enzyme 
that resists to high temperatures and performs its catalytic function at approximately 72ºC. 
These three steps are repeated for a number of cycles and the amount of DNA duplicates at each 
cycle. 
The PCR reactions were performed using for each sample 2 µl of 10X reaction buffer, 
0.4 µl of dNTPs (10mM), 0.4 µl of each forward and reverse primers (10mM; Table 2), 0.08 µl 
of Taq DNA polymerase (5U/µl), 2 µl of diluted synthesized cDNA and milliQ water to reach 
a total 20 µl of reaction solution. PCR was carried out in a Thermal Cycler and began with a 
denaturation step at 95ºC for 5 minutes, followed by 22 cycles of denaturation at 95ºC for 30 
sec, annealing at the respective temperature (Table 2) for 30 sec and synthesis at 72ºC for 30 
sec. A final elongation step was performed at 72ºC for 5 minutes. At the end, the amplification 
was confirmed by running samples by electrophoresis in a 2% TAE-agarose gel with Ethidium 
bromide (0.1 %) and analyzing it in under UV light. 
 
1. Primer design for target gene 
The pair of primers used for PCR were the same used in qPCR. Although qPCR is a 
more sensitive technique requiring a smaller amplicon size for detection, a pair of primers 
design for it can be used in PCR, but not the other way around. 
To design a specific pair of primers for each gene it is necessary to have a nucleotide 
sequence of the gene, against which the primers sequences will be homologous. This nucleotide 
sequence was obtained by searching the genome database of the National Centre for 
Biotechnology Information (http://www.ncbi.nlm.nih.gov/). The primers were designed using 
both Beacon Designer and Primer Premier Software taking in consideration general parameters 
such as:  
 Primers size should be between 18 and 22 bp; 
 Melting temperature should be between 52 and 58 ºC; 
 Avoid runs of four or more bases, as it reduces annealing efficiency;  
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 Presence of G and C bases should be between 40 and 60%; 
 Avoid the presence of secondary structures between the pair of primers such as 
hairpin, self-dimer and cross-dimer; 
 Avoid cross-homology where a pair of primers can amplify a sequence in other 
gene, by running a BLAST (http://blast.ncbi.nlm.nih.gov/Blast.cgi) with the 
primers sequences. 
Table 2 - Primer sequences for both PCR and RT-PCR reactions, forward (Fw) and reverse (Rv). The annealing 
temperature (Ta) at which the pair of primers anneal with complementary cDNA and the amplicon size in base 
pairs (bp). 
Gene Primer sequence (5’  3’) Ta (ºC) 
Amplicon size 
(bp) 
PiT-1 
Fw CTGCTGTTACTGCTTCCGCTCCAC 
60 163 
Rv CAGGCTTGCTTCAGGGTCACTACAC 
PiT-2 
Fw AGAGGGTGGTGTGGAAATGAG 
61 150 
Rv CCGAAGCAGGCAGTGAGG 
NaPi2a 
Fw ACACGCCTGCCCATACG 
61 156 
Rv GCCCACTCCGACCATAGC 
NaPi2b 
Fw TTTGCTTGGCTGACTGGCTACC 
60 140 
Rv AGTGGATATGCCCTCTCAATGC 
α-klotho 
Fw GTAACCAGACCCAAGTGAACC 
57 184 
Rv GCAAACGCCAGAGCAGTG 
XPR1 
Fw GGGAACATCATTGCTACTGTCTTTG 
60 181 
Rv CCTGGTCCATCATCTGCTCAAG 
PCNA 
Fw GGTTGGTAGTTGTCGCTGTAGGC 
60 130 
Rv CTCAAACATGGTGGCGGAGT 
18S 
Fw TGACGGAAGGGCACCACCAG 
60 158 
Rv GCGTTCTTAGTTGGTGGAGCGATT 
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2. 18S ribosomal (r) RNA PCR 
To assess the quality and reliability of the synthesized cDNA, a PCR amplification of 
18S ribosomal (18S) gene was performed, which served as an internal control, as it is expressed 
in abundance in all organisms and cell types. The PCR reaction was carried out as described in 
the section 2.3.5.  
 
3. Real-Time qPCR 
Real-Time quantitative PCR (qPCR) is a technique for gene-expression analysis very 
similar to traditional PCR. This method benefits from its sensitivity, large dynamic range as 
well as accurate quantification of specific gene expression that is measured after each round of 
amplification instead of the traditional PCR method. The concept of qPCR relies on the 
detection of amplified product using a fluorescent marker (SYBR Green) that binds to the DNA 
molecules. During amplification the fluorescent signal is increased, which is directly 
proportional to the amount of DNA produced during each PCR cycle.  
This linear correlation between qPCR product and fluorescence intensity is used to 
calculate the amount of template present at the beginning of the reaction. The point where the 
fluorescence is first detected as statistically significant above the background is called the 
threshold cycle or Ct value.  
The qPCR reactions were performed using, for each sample, 5 µl of Evagreen (Bio-
Rad), 0.45 µl of each forward and reverse primers (10mM; Table 2), 2 µl of the diluted 
synthesized cDNA and milliQ water to obtain 10 µl of reaction solution. qPCR reactions were 
carried out in a StepOnePlus™ Real-Time PCR System (Thermo Scientific) and in 
an iCycler iQ™ Real-Time PCR Detection System (Bio-Rad), and began with a denaturation 
step at 95ºC for 30 sec, followed by 40 cycles of denaturation at 95ºC for 5 sec, annealing at 
the respective temperature (Table 2) for 10 seconds and synthesis at 60ºC for 10 sec. In the end, 
the amplification was confirmed by running samples by electrophoresis in a 2% TAE-agarose 
gel with Ethidium bromide (0.1 %) and analyzing it in under UV light. 
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4. Standard curve  
A standard curve is obtained by running qPCR reactions of a dilution series of a template 
containing the fragment of interest. This standard curve can be used to relate the quantity of 
amplicon amplified from the known concentration of the starting material to a given Ct. To 
determine the starting amount of the target gene in the cDNA samples analyzed, their Ct 
obtained by qPCR is related to a concentration value obtained from the standard curve which 
is run in the same plate as the cDNAs. 
 
5. Normalization 
Normalizing to a reference gene is a simple method for internally controlling for error 
in qPCR, the amount of starting material and variation of reverse transcription efficiencies. 
Among the most used housekeeping genes is 18S rRNA, expressed constitutively and involved 
in basic housekeeping functions required for cell maintenance, and their expression is assumed 
to be unaffected by most experimental parameters.80 Reference genes must be validated for a 
particular experimental condition and in this study were used 18S rRNA.  
 
 
 Statistical analyzes  
The results are expressed as mean ± SEM. The difference between means for two groups 
and between means at different time-points within a single group was determined using Two-
Way ANOVA multiple comparisons, explicitly Sidak's multiple comparisons test, where 
p≤0.05 was considered statistically significant. 
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3. Results and discussion 
The first goal of this study was to evaluate gene expression of PiT-1, PiT-2 and related 
genes in several tissues. With the resultant data, it aimed to better understand their distribution 
in tissues of the immune system, such as thymus and spleen, and tissues from the transport and 
absorption systems, such as kidney, duodenum, small intestine and bladder.  
Later, to assess the role of extracellular phosphate, cotransporters PiT-1 and PiT-2, and 
related genes in cell development and proliferation, the phosphate availability was modulated 
in cell culture assays. To this end, the EL-4 cell line was used, which is derived from a mouse 
thymic lymphoblastic lymphoma. These assays were complemented with assays performed 
with thymic cells from wild-type and leukemic transgenic mice, that developed acute 
lymphoblastic leukemia (ALL). Consequently, cell proliferation, 33Pi uptake assays and gene 
expression associated with these assays were evaluated.  
 
 Gene expression in tissues 
An initial examination of the expression pattern of phosphate cotransporters and 
associated genes was performed in a variety of tissues that belong to the renal and immune 
systems, among others. This had the purpose of better understanding and complementing the 
information already known from the literature. 
The widespread expression of both PiT-1 and PiT-2, described by Hernando et al 
attributing them a housekeeping role in phosphate transport5,21, was confirmed in the 
quantitative real-time PCR analyses of RNA extracted from this tissues (Figure 3.1). The 
expression of both PiT-1 and PiT-2 was also detected in the small intestine and kidney justifying 
their moderate contribution (approximately 5%) to the transepithelial transport in these organs.5 
It was also observed a higher expression of PiT-2 across tissues, when compared with PiT-1. 
The published information about PiT-1 and PiT-2 expression reveal a contrary information, 
where PiT-1 is the more expressed in all tissues.5 Although the functional distinction between 
these two proteins remains to be clarified, it is mentioned that both proteins share only 60% 
homology,67 which may signify that both gene promotors only share 60% homology as well. 
As the need for two different proteins that are described to have the same function is not 
elucidated, this difference in their gene expression may be related with the possible difference 
that distinguish these two proteins and their possible need in different circumstances.   
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PiT-1 is associated with novel cellular metabolism roles like bone phosphate 
homeostasis69, liver development36, parathyroid function34 and cell proliferation66, and these 
different functions between these two proteins may require the synthesis of different quantities 
of mRNA. 
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Figure 3.1 – Tissue-specific gene expression/distribution of type III Na+/Pi cotransporters, PiT-1 and PiT-
2, in a wild-type strain mouse, C57BL/6. Both quantitative (A) and qualitative (B) expression were evaluated 
in tissues as liver, thymus, spleen, kidney, duodenum, small intestine and bladder. (A) Quantitative real-time 
PCR analyses of RNA from tissues was estimated in copy numbers where the results are represented in means 
(n=1; with 2 technical replicates). Data was normalized with the reference gene, 18S. (B) Qualitative gene 
expression was evaluated by running samples by electrophoresis in a 2% TAE-agarose gel with Ethidium 
bromide (0.1 %) and analyzing it in under UV light. 
 
 
The main organs involved in phosphate homeostasis are the small intestine and kidney, 
and the main membrane transporters are NaPi-IIb and NaPi-IIa, respectively.4,5,21 As depicted 
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in Figure 3.2, NaPi-IIa was mostly expressed in kidney with residual expression in the 
remaining organs, as described by Biber et al.27,52,81 Its expression was 3-fold higher than the 
quantity of PiT-1 and PiT-2 (Figure 3.1), and NaPi-IIb (Figure 3.2). NaPi-IIb found to be 
mostly expressed in tissues of gastrointestinal tract such as duodenum and small intestine but 
also kidney, bladder and thymus, although its highest expression was detected in the small 
intestine as described by Fosters et al.16,46 
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Figure 3.2 – Tissue-specific gene expression/distribution of type II Na+/Pi cotransporters, NaPi-IIa and 
NaPi-IIb, in a wild-type strain mouse, C57BL/6. Both quantitative (A) and qualitative (B) expression were 
evaluated in tissues as liver, thymus, spleen, kidney, duodenum, small intestine and bladder. (A) Quantitative 
real-time PCR analyses of RNA from tissues was estimated in copy numbers where the results are represented 
in means (n=1; with 2 technical replicates). Data was normalized with the reference gene, 18S. (B) Qualitative 
gene expression was evaluated by running samples by electrophoresis in a 2% TAE-agarose gel with Ethidium 
bromide (0.1 %) and analyzing it in under UV light. 
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XPR1 had a broad expression pattern as described in the literature by Wege and 
Giovannini et al6,38 although its highest expression was detected in the kidney and duodenum 
(Figure 3.3). This phosphate exporter is present in a range of cells such as pancreatic B cells, 
hepatocytes, jejunal enterocytes and renal proximal tubules cells38, and the amount of cells 
transporting Pi is much higher when transporting in tissues. As seen in Figure 3.3, cells have 
different expression patterns among the tissues. In thymus, kidney and duodenum the number 
of copies was elevated, which for a housekeeping function a few are enough. This indicate that 
these tissues have an elevated rate of Pi export that would only be necessary if these same 
tissues had an elevated rate import, which is already known to be true. Body phosphate 
homeostasis is largely dependent by modulation of intestinal absorption of dietary phosphate, 
and renal phosphate reabsorption and excretion.13 
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Figure 3.3 – Tissue-specific gene expression/distribution of a XPR1, a protein membrane appointed as a 
phosphate efflux transporter, in a wild-type strain mouse, C57BL/6. Both quantitative (A) and qualitative 
(B) expression were evaluated in tissues as liver, thymus, spleen, kidney, duodenum, small intestine and 
bladder. (A) Quantitative real-time PCR analyses of RNA from tissues was estimated in copy numbers where 
the results are represented in means (n=1; with 2 technical replicates). Data was normalized with the reference 
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gene, 18S. (B) Qualitative gene expression was evaluated by running samples by electrophoresis in a 2% TAE-
agarose gel with Ethidium bromide (0.1 %) and analyzing it in under UV light. 
 
 
The α-klotho is mainly expressed in renal distal tubules in kidney59, which was verified 
in Figure 3.4 where it plays his major role as co-receptor of FGFR1. Although it was expressed 
in all analyzed tissues, its expression in kidney was 200-fold higher when compared to the other 
tissues. Again, expression in thymus was quite high, at the levels of what was observed in 
bladder, and much higher than that of the gastrointestinal tissues, an observation that requires 
further investigation.  
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Figure 3.4 – Tissue-specific gene expression/distribution of α-Klotho, a FGF co-receptor, in a wild-type 
strain mouse, C57BL/6. Both quantitative (A) and qualitative (B) expression were evaluated in tissues as liver, 
thymus, spleen, kidney, duodenum, small intestine and bladder. (A) Quantitative real-time PCR analyses of 
RNA from tissues was estimated in copy numbers where the results are represented in means (n=1; with 2 
technical replicates). Data was normalized with the reference gene, 18S. (B) Qualitative gene expression was 
evaluated by running samples by electrophoresis in a 2% TAE-agarose gel with Ethidium bromide (0.1 %) and 
analyzing it in under UV light. 
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 EL-4 cells in FBS starvation and the recovery after a quiescent state. 
To evaluate phosphate function and phosphate transporters expression and their role in 
cell proliferation, was used the EL-4 cell line. This line was previously established from a 
lymphoma from T cell. To better understand the cell line behavior in culture and cell 
proliferation pattern it was first performed a fetal bovine serum (FBS) starvation and followed 
by cell cycle reactivation after a quiescent stage.  
An initial evaluation of the cell growth ratio (Figure 3.5) showed that after 48h of 
incubation with a low percentage of FBS (0.1%), cells entered in a stage of quiescence and 
inactivity. In the absence of growth factors, cells exit the cell cycle, termed G0, characterized 
by low metabolic activity82. When comparing these two conditions, either normal or low serum, 
at the same time-point, 48h, it is evident that 0.1% FBS had a lower than 2-fold growth and the 
positive control (10% FBS) had almost a 7-fold growth. Upon the addition of FBS at 48h, 
quiescent and proliferative cell cultures were exposed to the same amount of FBS. It is evident 
in Figure 3.5 that 24h later, EL-4 cells rapidly recovered from the inactive into a proliferative 
state.82  
Following the cell growth evaluation (Figure 3.5) a phosphate uptake assay was 
performed (Figure 3.6) to understand whether cell activity was associated with differential 
phosphate uptake. First, it was performed a phosphate uptake curve using a radioactive assay 
in normal conditions (10% of FBS and 6 mM phosphate) in EL-4 cells (Figure 3.6A and B) to 
estimate the rate of Pi uptake in EL-4 cells for future uptake assays. As it can be seen in Figure 
3.6A, the rate of counts per minute (cpm’s)/time of incubation counted in cells at the first 5 
minutes was higher than 30 or 60 minutes later, where the number of cpm’s did not even 
duplicate. In the first 5 minutes the number of cpm’s had a rapid increase, velocity that when 
approaching the 15 minutes started to decrease and from 30 minutes on was reduced to almost 
stop, reaching a plateau phase, where the number of cpm’s seemed to stagnate nearly below 
1000. This indicates that at this point the tracer had nearly equilibrated with the Pi pool inside 
the cells. 
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Figure 3.5 – Cell count in EL-4 cells in FBS starvation and the recovery after a quiescent state. Cells were 
seeded at a concentration of 2.5x105 cells/ml in 100 mm Petri dishes at two different conditions: 0.1%FBS and 
control, 10%FBS. At the 48h time-point both cell culture medium was changed and replaced with medium with 
10% FBS to evaluate cell recovery from a quiescent state. Cells were counted using Neubauer counting chamber 
at the indicated hours, and the results are shown as the mean ± SEM (n=3; with 3 technical replicates) of cell 
growth ratio were the data was normalized with the initial cell number (0h); ****, p<0.0001.  
 
 
Figure 3.6B, shows the uptake of phosphate (nmol) per minute, data calculated using 
the number of cpm's (Figure 3.6A) and the exact quantity of Pi (nmol) present in the medium 
used (methodology section). At 5 minutes the uptake was about 3-fold higher than the rest of 
the time-points, and given the fact that the number of cells was always the same, this data 
suggests that the first minutes of cells incubation in the medium is the time where the highest 
uptake happens. At the beginning, the extracellular medium has a higher quantity of phosphate 
than intracellular, and the uptake occur rapidly until the cell starts to reach an equilibrium where 
the uptake of ions occurs at the same velocity as the exit of ions. This uptake course over time 
is prevalent in other cells as parathyroid gland cells34 and intestinal brush border cells.26 
Following these primary uptake tests, phosphate uptake assays were performed using 
two different FBS conditions, 0.1% and 10%, and only two different time-points, 5 and 30 
minutes, corresponding where uptake occur rapidly and where the uptake reaches a plateau 
phase. At 48h there was a difference in uptake between the 0.1% and 10% FBS treatments, 
where in the first, the Pi uptake was lower than the positive control (Figure 3.6C). This data 
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would be expected when looking simultaneously to the cell growth data at the same conditions 
(Figure 3.5).  Cells that entered a stage of inactivity because of the absence of growth factors 
have low metabolic activity, so will require less phosphate and then its uptake is also 
diminutesished.82 It is also important to refer that the difference in the uptake between the two 
time-points (5 and 30 minutes) was maintained in both FBS conditions, although at 10% FBS 
this difference was sharper. At 72h, when cell recover to a proliferative stage, phosphate 
intracellular pool increases and so does increase the Pi uptake to content cellular needs. Here 
no significant differences were observed between the two treatments. 
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Figure 3.6 – Phosphate uptake in EL-4 cells in FBS starvation and the recovery after a quiescent state. 
Cells were seeded at a concentration of 2.5x105 cells/ml in 100 mm Petri dishes at two different conditions: 
0.1%FBS and control, 10%FBS. At the 48h time-point both cell culture medium was changed and replaced with 
medium with 10% FBS to evaluate cell recovery from a quiescent state. To calculate the Pi uptake over time it 
were collect 4 samples of 1x106 cells for each time-point (0, 5, 15, 30 and 60 minutes) that cells were incubated 
with the 33P radioisotope for the Pi uptake measurement. (A) The counts per minute (Cpm) measured by the 
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luminescence counter for each time-point are represented as mean ± SEM (n=2; with 4 technical replicates). 
(B) The phosphate uptake (nmol) per minute that enter the cell at each time-point is represented as mean ± SEM 
(n=2; with 4 technical replicates). (C) At the 48h time-point it were collect 4 samples of 1x106 cells from each 
condition for each time-point (5 and 30 minutes) that the cells were incubated with the 33P radioisotope. After 
that both cell culture medium was changed and replaced with medium with 10% FBS to evaluate cell recovery 
from a quiescent state. At the 72h time-point it were again collect 4 samples of 1x106 cells from each condition 
to perform the same assay. The phosphate uptake (nmol) at each time-point is represented as mean ± SEM (n=2; 
with 4 technical replicates); **, p<0.0026; **, p<0.0032; ***, p=0.0004.  
 
 
Later on, a quantification of gene expression was performed in EL-4 cells that had been 
submitted to the same FBS conditions (0.1% and 10%) at 48h and 72h. Although at 48h the 
cellular proliferation activity at 0.1% FBS was reduced, the gene expression of PCNA (Figure 
3.7), a proliferating cell marker, did not seemed to show significant changes when compare 
with the positive control (10% FBS). It would be expected a lower PCNA expression when cell 
activity is reduced.82  
It is also important to note that α-klotho expression in 0.1% FBS treatment was 2-fold 
higher than the proliferative stage (10% FBS). Secreted α-klotho functions as an aging 
suppressor. In certain cell lines, negates senescence phenotypes by regulating the mitogen-
activated kinase pathway, an apoptotic pathway, and in mice, when overexpressed extends 
lifespan in about 20-30%. Also in mice, when disrupted, accelerates development of aging-like 
phenotypes.57,58 In the 0.1% FBS treatment there is an absence of growth factors, so cells exit 
the cell cycle and there is no cell senescence. It makes sense that α-klotho expression was 
higher, to maintain this no-aging state. 
Adding to this data, both PiT-2 and XPR1 decreased in the quiescent stage, more 
significantly XPR1 that showed a 9-fold lower expression than at proliferative stage. This data 
may suggest that in a stage of low cell proliferation both phosphate import, partially executed 
by PiT-24,5, and export, possibly performed by XPR138, in cells are reduced corresponding to 
cell necessities. 
54 
 
Q
u
a
n
t
it
y
(c
o
p
y
 n
u
m
b
e
r
)
0 .1 % 1 0 % 1 0 % 1 0 %
0
4 .01 0 -4
8 .01 0 -4
2 .01 0 0
4 .01 0 0
1 .61 0 1
1 .81 0 1
2 .01 0 1
P C N A
P iT - 1
P iT - 2
X P R 1
 -K lo th o
4 8 h 7 2 h
F B S  a d d e d  a t  4 8 h .
B o th  c o n d i t io n s  h a v e
1 0 %  F B S .
 
Figure 3.7 – Gene expression in EL-4 cells in FBS starvation and the recovery after a quiescent state. For 
the gene expression was recovered from each indicated time-point (at 48h before the addition of FBS and at 
72h) 9x106 of cells, 1x106 cell for each technical replicate in each experimental replicate, that were combined 
in a single sample. The quantitative expression of PCNA, a proliferating cell marker, PiT-1 and PiT-2, type III 
Na+/Pi cotransporters, XPR1, phosphate efflux transporter and α-klotho, FGF co-receptor, was evaluated by 
real-time PCR analyses where the RNA from cells was estimated in copy numbers and the results are 
represented in means (n=1; with 1 technical replicate). Data was normalized with the reference gene, 18S. 
 
 
 EL-4 cells proliferation under variable phosphate availability 
Following the FBS starvation experiment, a phosphate availability assay was performed 
in EL-4 cells for a period of 96h. Five different concentrations of phosphate were tested and in 
all these conditions phosphate free medium (with residual phosphate of 0.32 mM), was used, 
to which different amounts of phosphate (phosphate Sorensen buffer; annex 1) were added as 
described in the methodology section. The most obvious phosphate concentration to be tested 
was 6 mM since it is the one used as standard in cell cultures, as in the positive control. Then 
was decided to cover a range of 4 concentrations from nominal 0 mM (0.32 mM – residual Pi 
concentration) until an highly excessive amount (18 mM Pi) and including 3 mM concentration 
that is similar to the concentration in the extracellular plasma, although only the ionic form, 
corresponding to 1.5 mM, is immediately available to cells.12,13,44 
Looking at the cell growth ratio (Figure 3.8A) is evident that at every 24h the cells of 
positive control (6 mM) duplicate, evidence that is followed by the 6 mM Pi condition. In the 
remaining Pi concentrations tested, the cells followed the 2-fold growth of the positive control 
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up to 48 h, from which it becamed evident a stagnation in the cell growth. The slower cell 
growth above the 48h of culture it is most likely to not be due to cell medium saturation, given 
the fact that all conditions had the same cell culture incubation (96h) and the positive control 
(6 mM) and the equivalent 6 mM, where the phosphate buffer was added to culture medium, 
followed the expected path. It may be related with pH variation upon addition of the phosphate 
buffer in the medium. This data demonstrates that the Pi concentration at what cells keep their 
optimum function does not differ much since 3 mM below or above was enough to retain cell 
proliferation above 48h of culture. Although one would expect optimal conditions between 1.5 
and 3 mM, but cells seem to remain better at 6 mM. The possible explanation to this result 
would be the fact that these cells are maintained at 6 mM in a standard culture for so long prior 
to these treatments that when changing conditions, for both or less phosphate, cells sense these 
variations as unusual and their proliferation is reduced. Interestingly, many cultivated cells 
perform better at elevated phosphate conditions. In a specific case, Pombinho et al showed that 
fish bone-derived cells required above normal physiological conditions to multiply and 
additional phosphate to mineralize, with 11.8 and 10.9 mM phosphate in L-15 and D-MEM 
culture medium, respectively, but only upon the addition of high values of calcium (final free 
calcium concentrations of 5.3 and 5.8 mM, about 4 times the ionic values in vertebrate plasma) 
would initiate mineralization of the cellular matrix.83 The added value of this high phosphate is 
intriguing but it may be related to apparent dependence of the internal medium of external 
phosphate concentrations demonstrated in the uptake assays (Figure 3.9). 
Alongside with the cell growth measurement it was also performed a cell viability assay, 
using the MTT (methodology section). It is apparent that when comparing the 48h with the 96h 
time-point, there was a general decrease in cell activity in the first one (Figure 3.8B). In this 
viability assay, cell proliferation differences shown in the various phosphate conditions in the 
cell growth ratio (Figure 3.8A) are not that evident, but one thing is clear, longer the duration 
of the assay, lower the cell proliferation. 
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Figure 3.8 – Cell count and viability in EL-4 cells under variable phosphate availability.  (A) Cells were 
seeded at a concentration of 2.5x105 cells/ml in 24 well plate in the different phosphate concentrations indicated 
(0.32, 3, 6, 9 and 18 mM) using as positive control 6 mM. Cells were counted using Neubauer counting chamber 
at the indicated hours, and the results are shown as the mean ± SEM (n=5; with 3 technical replicates) of cell 
growth ratio were the data was normalized with the initial cell number (24h); ****, p<0.0001. (B) Cells were 
seeded at a concentration of 2.5x105 cells/ml in 96 well plate in the different phosphate concentrations indicated 
(0.32, 3, 6, 9 and 18 mM) using as positive control 6 mM. At the indicated hours, the MTT assay was performed, 
the absorbance was measured on an ELISA plate reader at a wavelength of 570 nm and the results are presented 
as mean ± SEM (n=3; with 3 technical replicates); *, p=0.0410. 
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Phosphate uptake was carried out in EL-4 cells under altered Pi concentrations 
previously described (Figure 3.8A and B). In continuity with the primary uptake tests performed 
(Figure 3.6A and B) only two different time-points, 5 and 30 minutes, were used. 
In the Figure 3.9 it is shown the phosphate uptake in EL-4 cells after an incubation of 
96h with various Pi concentrations in the cell culture medium. Is evident that the higher the Pi 
concentration present in the cell culture medium, the higher the uptake. This perception 
becomes more evident at the 5 minutes time-point of incubation with the 33Pi radioisotope, 
rather than at the 30 minutes time-point, confirming the Figure 3.6A and B data and the reason 
why this two time-point were chosen. It is possible that a sensing mechanism allowed the cell 
to adjust to such Pi variations at long-term.17,62 Although at higher Pi concentrations (9 and 18 
mM) the difference between the two time-points became more significant, if only taken in 
account the 30 minutes growth along the Pi conditions. It is evident that besides the existence 
or not of a sensing mechanism, cellular uptake depends on the Pi quantity present in the 
extracellular medium, which points to a less than perfect modulation of Pi balance. This 
deserves further investigation. 
When comparing the positive control (6 mM) with the Pi condition where the same 
amount was added to the medium and even at lower concentrations (3 mM), there seems to be 
a slight rise in these last ones, although this increment was not significant.  
At the 48h and 96h time-point of the cell culture was assessed a gene expression 
quantification (Figure 3.10) of the type III Na+/Pi cotransporters, PiT-1 and PiT-2 (Figure 3.10A 
and B), type II Na+/Pi cotransporters, NaPi-IIa and NaPi-IIb (Figure 3.10C and D), phosphate 
efflux transporter, XPR1 (Figure 3.10E), proliferating cell marker, PCNA (Figure 3.10F) and 
FGF co-receptor and anti-aging gene, α-klotho (Figure 3.10G). These results came from 
primary tests which need to be repeated and confirmed but it is showed that the majority of the 
genes had lower expression at 96h comparing with 48h in any phosphate concentration, which 
can be associated with a lower cell viability at 96h (Figure 3.8B). This lower cell metabolic 
activity will be reflected in the reduced mRNA transcription and consequent protein 
transduction. Supporting this hypothesis is the PCNA expression (Figure 3.10F), a proliferating 
cell marker, that at 96h was expressively lower compared with 48h, being also the only gene 
where this difference was most noticed. 
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Figure 3.9 – Phosphate uptake in EL-4 cells under variable phosphate availability. Cells were seeded at a 
concentration of 2.5x105 cells/ml in 24 well plate for a total of 96 h in the different phosphate concentrations 
indicated (0.32, 3, 6, 9 and 18 mM) using as positive control 6 mM. To calculate the Pi uptake in cells after an 
incubation of 96 h, it were collect 4 samples of 1x106 cells from each condition for each time-point (5 and 30 
minutes) that the cells were incubated with the 33P radioisotope. The phosphate uptake (nmol) at each time-
point is represented as mean ± SEM (n=2; with 4 technical replicates); *, p=0.0132; **, 0.0023<p<0.0051; ***, 
0.0002<p<0.0006; ****, p<0.0001. 
 
Looking at the cotransporters NaPi-IIa and NaPi-IIb (Figure 3.10C and D), there 
seemed to be no pattern change according to phosphate variation or in the different time-points 
(48h and 96h). For example, the expression quantity at 0.32 mM Pi was lower compared with 
18 mM Pi, a much higher concentration, but higher than 6 mM Pi. The EL-4 cell line used in 
these experiments derive from a T cell lineage and as described previously, NaPi-IIa and NaPi-
IIb execute their function mainly in kidney and small intestine, respectively, although their 
expression has been detected in other tissues (Figure 3.2). NaPi-IIa and NaPi-IIb showed a 
lower expression comparing with both PiT-1 and PiT-2, in a fold range between 3 and 4, being 
NaPi-IIa the gene that was less expressed. This difference between both SLC families had 
already been seen in Figure 3.1 and 3.2 and it was in concordance with data published by Biber 
et al, where both PiT-1 and PiT-2 have an expression 100-fold range higher than NaPi-IIa and 
NaPi-IIb.5 
When it comes to the cotransporters PiT-1 and PiT-2 (Figure 3.10A and B), there seems 
to be a slight decrease in their expression at 96h time-point, but there was no pattern change 
according to phosphate variation. There was also no consistence between the positive control 
(6 mM) and the equivalent Pi added condition. If the uptake increases with higher extracellular 
phosphate, the transporters that are responsible for that uptake should also increase, specially 
PiT-1 and PiT-2 that play their function in all types tissues.31 It was notable a 10-fold higher 
expression of PiT-2 comparing with PiT-1, a difference that was also seen in Figure 3.1, 3.2, 
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3.3, 3.4 and 3.7, however in a different fold range. A potential role of PiT proteins in Pi sensing 
has been described as being important for cellular functions, such as proliferation17,66, and 
although there are indications of an existent sensing mechanism (Figure 3.9), nothing in the 
Figure 3.10A and B points to that case. 
Several studies have suggested that PiT-1 may be involved in the p38 mitogen activated 
protein kinase (MAPK) and tumor necrosis factor alpha (TNFα) apoptotic pathways35,66 The 
p38 MAPK pathway regulates cellular functions such as gene expression, differentiation, 
mitosis, cell survival and proliferation, but is described to have a key role in delaying the G2/M 
phase transition.84 Here it was observed that PiT-1 expression was downregulated at all 
phosphate concentrations at 96h which is when cell viability was also reduced according to the 
MTT assay. However it was not analyzed the frequency of cells in each phase of the cellular 
cycle nor used any marker for cellular apoptosis. Beck et al showed that PiT-1 depletion 
enhanced the phosphorylation of p38 MAP kinase thus affecting cytokinesis in HeLa cells, in 
parallel with a reduction of tumor growth in nude mice inoculated with PiT-1 knockdown HeLa 
cells.35 TNFα is a cytokine that may activate either anti-apoptotic or pro-apoptotic pathways85 
and apparently also increase the expression of PiT-1 in diverse cell types86. PiT-1 depletion 
increases the TNFα pro-apoptotic activity mediated by the caspase-8 pathway.66 
The effect of PiT-1 in cell proliferation and protection against apoptosis was not shared 
with PiT-2.35,66 However, in assays performed in this investigation, both genes show similar 
apparent reduction in expression at 96h when compared to 48h, which occur in parallel with a 
decrease in the expression of the proliferative marker gene PCNA. So both PiT-1 and PiT-2 
appear to be important for EL-4 proliferation, although their specific role was not investigated. 
This TNFα-induced up-regulation of PiT-1 prompted the question whether PiT-1 could 
be involved in protection against apoptosis. Later it was discovered that PiT-1 depletion 
increases the TNFα pro-apoptotic activity mediated by the caspase-8 pathway.66 In both 
proliferation and protection against apoptosis it was shown that the effect of PiT-1 was not 
shared with PiT-2.35,66  
In Figure 3.10E and G is shown that both XPR1 and α-klotho expression pattern are 
unclear, as the other previous genes according to phosphate variation or in the different time-
points (48h and 96h), although XPR1 seemed to be highly expressed in the highest phosphate 
concentration, perhaps to facilitate Pi excretion from the cell. PiT-1 had the same expression 
range of XPR1, or even higher, as is the case of PiT-2. Phosphate uptake performed by these 
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two cotransporters in these cells during this assay had as response, the Pi export by XPR138 to 
maintain the intracellular pool equilibrium. This XPR1 high expression was due to a response 
to cellular needs. 
In conclusion, the growth rate variances caused by the different Pi availability in the cell 
culture medium, the increase in the uptake along with extracellular Pi increase, and gene 
expression indicate that both PiT-1 and PiT-2 appear to be important for EL-4 proliferation. 
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Figure 3.10 – Gene expression in EL-4 cells under variable phosphate availability. Cells were seeded at a 
concentration of 2,5x105 cells/ml in 24 well plate in the different phosphate concentrations indicated (0.32, 3, 
6, 9 and 18 mM) using as positive control 6 mM. For the gene expression was recovered from each indicated 
time-point 9x106 of cells, 1x106 cell for each technical replicate in each experimental replicate, that were 
combined in a single sample. Quantitative expression of (A) PiT-1 and (B) PiT-2, type III Na+/Pi cotransporters, 
(C) NaPi-IIa and (D) NaPi-IIb, type II Na+/Pi cotransporters, (E) XPR1, phosphate efflux transporter, (F) PCNA, 
proliferating cell marker and (G) α-klotho, FGF co-receptor and anti-aging gene,  was evaluated by real-time 
PCR analyses where the RNA from cells was estimated in copy numbers and the results are represented in 
means (n=1; with 1 technical replicate). Data was normalized with the reference gene, 18S. 
 
 
 Wild-type and leukemic thymic cells from mice 
Both lymphoblastic lymphoma and leukemia derive from the same cell type, 
lymphocytes. The EL-4 cells are an established cell line and the leukemic cells collected from 
mice are not established, which means that although it were prevenient from a TEL-JAK2 
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transgenic mice, there was no way to be certain if all the collected cells were leukemic cells, 
with the possibility of being present some wild-type cells. So these two cell types and the assays 
that have been performed in both of them complement each other.  As control it were used cells 
from wild-type animals as well.  
A preliminary cell count was performed for an initial distinction in cells from the 
different types of animals. Tumorigenic tissues are characteristic for resisting to cell death, 
enabling replicative immortality and an enhanced proliferative rate that will result in abnormal 
cell growth higher cell number.75 This last characteristic were observed in Figure 3.11 where 
the number of cell present in leukemic thymus is 2-fold higher than the cells in wild-type 
thymus. 
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Figure 3.11 – Cell counts in the WT and leukemic thymus. Thymus was recovered from mice and cell 
extraction was performed right after. Cells were counted using Neubauer counting chamber at the indicated 
hours, and the results are shown as the mean ± SEM (n=3) of cell number present in thymus from each type of 
animal; **, p=0.0011. 
 
 
After recovering cells from thymus and to guarantee that the mice was actually leukemic 
as exterior evidences indicated (slower locomotion movements, overweight and swelling of the 
thymus, spleen and lymph nodes showed) an immunostaining technique was used. The results 
represented in Figure 3.12 show existence of two different cell types, each one in a different 
animal. Mature wild-type thymus cells, before exiting the thymus, express both CD4 and CD8 
(double positive) and represent the bigger percentage of cells.72,73 In Figure 3.12A, double 
positive cells represent about 81%, comparing with single positive and double negative cells, 
represented in a much lower percentage.  
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In leukemic mice, the mature leukemic cells express a higher quantity of CD8 when 
comparing with wild-type cells, which will result in a percentage of single positive CD8 equal 
or even bigger to the double positive cells.72,73 And in Figure 3.12B the percentage of double 
positive cells is 30.11% and the CD8 single positive is higher, 42.84%, showing that they were 
in fact leukemic cells recovered from an diseased animal.  
 
 
 
Later on, after confirming that the collected cells from thymus where actually from 
different animals, WT and leukemic, a gene expression was assessed to quantify and evaluate 
the differences between the two different cell types. In general, gene expression in this thymic 
collected cells had a lower quantity when comparing with the same gene expression in EL-4 
cells assays.  
PCNA, a proliferative marker, has a lower quantity expression in leukemic cells 
comparing with wild-type cells. This outcome was unexpected, given the fact that tumorigenic 
cells are characterized for a sustaining proliferative signaling as well as enabled replicative 
immortality.75  
 
Figure 3.12 – Cell surface fluorescent immunostaining in wild-type and leukemic thymus cells from mice, 
C57BL/6 strain and TEL-JAK2 transgenic, respectively. Cell suspensions from thymus were obtained from 
wild-type and transgenic leukemic animals. The CD4 and CD8 expression pattern of unsorted cells from (A) 
wild-type and (B) leukemic animals was determined by flow cytometry. For each experiment, 1x106cells were 
incubated with anti-CD4-PE (Y-axis) and anti-CD8-PE/Cy5 (X-axis) and analyzed by flow cytometry. The 
results were computed from the acquisition of 10 000 events. The relative percentage of each subpopulation is 
indicated in the corresponding area of the diagrams. 
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PiT-1 had lately been associated with cell proliferation and cell density. Depletion of 
PiT-1 expression in HeLa cells resulted in reduced cell proliferation and impaired mitosis,35 
and over-expression of PiT-1 increased proliferation in density-inhibited cell lines.70 In the Fi. 
3.13, this was not observed, as the expression of PiT-1 in leukemic cells was actually lower 
comparing with wild-type cells. PiT-2 had also the same expression, where its expression in 
WT cells was higher than in leukemic cells. It is also noteworthy the expression pattern between 
PiT-1 and PiT-2, where PiT-2 was about 2-fold higher than PiT-1 in both WT and leukemic 
cells, data also seen in Figure 3.7 and 3.10.  
Relatively to NaPi-IIa and NaPi-IIb, both of them are more expressed in leukemic cells 
than WT cells and it is also important to notice that they both have a 300-fold lower expression 
when comparing with PiT-1 and PiT-2, results also observed in Figure 3.1A, 3.2A and 3.10, 
and described by Biber et al.5 
XPR1 (Figure 3.12C) did not show any differences between WT and leukemic cells, 
although both PiT-1 and PiT-2 had expressed those differences. Comparing both Pi importers 
and exporter, XPR1 had a much lower expression. Phosphate uptake performed by PiT-1 and 
PiT-2 did not had an adequate response by XPR1.38 Somehow in this case the exporter 
housekeeping role is maintained at a low rate due to cellular needs. 
α-klotho showed a 2-fold higher expression when comparing the leukemic with WT 
cells (Figure 3.12E). Novel studies have been relating α-klotho as a tumor suppressor by 
inhibiting Wnt signaling pathway, well known for its role in cell fate, proliferation and 
migration.59 Given this, it would be expected a higher expression of α-klotho in wild-type cells, 
where tumor suppression is being placed, but this was not observed, as it happened the contrary. 
 
Q
u
a
n
t
it
y
 (
c
o
p
y
 n
u
m
b
e
r
)
P iT - 1 P iT - 2
0
5 .01 0 -4
1 .01 0 -3
1 .51 0 -3
* *
A
    
Q
u
a
n
t
it
y
 (
c
o
p
y
 n
u
m
b
e
r
)
N a P i- I I a N a P i- I I b
0
5 .01 0 -7
1 .01 0 -6
1 .51 0 -6
2 .01 0 -6
B
 
65 
 
Q
u
a
n
t
it
y
 (
c
o
p
y
 n
u
m
b
e
r
)
X P R 1
0
2 .01 0 -5
4 .01 0 -5
6 .01 0 -5
C
    
Q
u
a
n
t
it
y
 (
c
o
p
y
 n
u
m
b
e
r
)
P C N A
0
5 .01 0 -4
1 .01 0 -3
1 .51 0 -3
2 .01 0 -3
D
    
Q
u
a
n
t
it
y
 (
c
o
p
y
 n
u
m
b
e
r
)
 - K lo th o
0
2 .01 0 -8
4 .01 0 -8
6 .01 0 -8
W T
L e u k e m ic
E
 
Figure 3.13 – Gene expression in in wild-type and leukemic thymus cells from mice, C57BL/6 strain and 
TEL-JAK2 transgenic, respectively. It were recovered thymus cells from each animal type, wild-type (WT) 
and leukemic.  For the gene expression were used 30x106 cells, 10x106 cells for each animal that were combined 
in a single sample. Quantitative expression of (A) PiT-1 and PiT-2, type III Na+/Pi cotransporters, (B) NaPi-IIa 
and NaPi-IIb, type II Na+/Pi cotransporters, (C) XPR1, phosphate efflux transporter, (D) PCNA, a proliferating 
cell marker and (E) α-klotho, FGF co-receptor, was evaluated by real-time PCR analyses where the RNA from 
cells was estimated in copy numbers and the results are represented in means ± SEM (n=3; with 2 technical 
replicate); **, p=0.0018;. Data was normalized with the reference gene, 18S. 
  
 
 Wild-type and leukemic thymic cells under variable phosphate 
availability 
A phosphate uptake assay was performed in cells ex vivo, similar to what was described 
for EL-4 cells. A phosphate uptake curve using a radioactive assay in WT cells in normal 
conditions (10% of FBS and 6 mM phosphate) was carried out to estimate the velocity of the 
Pi uptake and verify if the response was as for EL-4 cells.  
As it can be observed in Figure 3.14A, the number of cpm’s counted in cells at the first 
5 minutes was higher when comparing with the next time-points. From the 15 minutes on the 
number starts to decrease reaching around the same number over time. In Figure 3.14B is 
showed the uptake of phosphate (nmol) per minute and at 5 minutes the uptake was about 2-
fold higher than at 15 minutes and 6-fold higher than the rest of the time points. This data were 
in agreement with the results obtain in EL-4 cells which makes sense giving the fact that both 
derive from the same cell type. In both cases, at the first minutes of incubation with radioisotope 
33P was the time where the majority of the uptake happened and from 30 minutes on it reached 
a plateau phase. This indicates that at this point the tracer had nearly equilibrated with the Pi 
pool inside the cells. 
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Later on, it was performed a phosphate uptake assay in thymic cells recovered from WT 
and leukemic mice using two different concentrations of phosphate: 0.32 mM and the positive 
control (6 mM). In continuity with the assay performed earlier (Figure 3.14A and B) it were 
used two time-points: 5 and 30 minutes. In the Figure 3.14C is shown the phosphate uptake in 
WT and leukemic thymic cells after an incubation for 1h with two phosphate conditions. Is 
evident that when comparing the 0.32 mM Pi condition with the positive control (6 mM), in the 
first one, the uptake was much lower in both WT and leukemic cells, presenting only residual 
values of uptake. Apparently, besides the existence or not of a sensing mechanism, cellular 
uptake depends on the Pi quantity present in the extracellular medium, which deserves further 
investigation. It is also evident that at the 5 minutes of incubation with the 33Pi radioisotope, 
the uptake was at its higher rate. This change in the uptake between the different time-points 
was not observed at the 0.32 mM condition where, with only a residual uptake, there was not 
enough phosphate to enter in the cell at the first 5 minutes neither there was enough Pi to reach 
the plateau phase. 
In Figure 3.14C there are no differences showed between the uptake in WT and 
leukemic cells, a factor that would not be expected because carcinogenic cells are known by 
their abnormal cell growth and enhanced proliferative rate75 Although it was unexpected, the 
result in 6 mM, was in agreement with PCNA expression (Figure 4.3D) that was lower in 
leukemic thymic cells. Following the data leukemic cells showed a lower Pi uptake and a lower 
PCNA expression when comparing with WT thymic cells. 
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Figure 3.14 – Phosphate uptake in the wild-type and leukemic thymic cells from mice, C57BL/6 strain 
and TEL-JAK2 transgenic, respectively, under variable phosphate availability. Cells were recovered from 
a wild-type animal and pre-warmed for 1h at normal conditions, 10% of FBS and 6 mM phosphate. To calculate 
the Pi uptake over time it were collect 4 samples of 1x106 cells for each time-point (0, 5, 15, 30 and 60 minutes) 
that cells were incubated with the 33P radioisotope for the Pi uptake measurement. (A) The counts per minute 
(Cpm) measured by the luminescence counter for each time-point are represented as mean ± SEM (n=2; with 4 
technical replicates). (B) The phosphate uptake (nmol) per minute that enter the cell at each time-point is 
represented as mean ± SEM (n=2; with 4 technical replicates). (C) Cells were recovered from the animals and 
pre-warmed for 1h with 10% of FBS at two different conditions, 0.32 mM of Pi and using a positive control of 
6 mM of Pi. To calculate the Pi uptake in cells after this 1h of incubation, it were collect 4 samples of 1x106 
cells from each condition for each time-point (5, and 30 minutes) that the cells were incubated with the 33P 
radioisotope. The phosphate uptake (nmol) at each time-point is represented as mean ± SEM (n=3 – 5; with 4 
technical replicates); *, 0.0265. 
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4. Conclusion 
This study focused on evaluate the role of extracellular phosphate in cell proliferation 
and the involvement of SLC20 members during this process. Consequently, tissue localization 
and expression levels of cotransporters PiT-1 and PiT-2, and related genes in mouse model 
were characterized in an attempt to establish its functional roles and involvement in normal and 
abnormal cell development and proliferation. It were used a lymphoblastic derived cell line 
(EL4), and wild-type and leukemic thymic cells removed from mice.  
Altogether, the results confirmed the tissues distribution of both SLC20 and SLC34 
family described in the literature. Interesting, XPR1 had an elevated expression in kidney and 
gastrointestinal tissues, known for an elevated rate of phosphate import and consequently 
export,  supporting its role as Pi exporter. The FBS starvation followed by cell cycle reactivation 
showed that after 48h, 0.1% FBS cultured cell, enter a quiescent stage that is recovered after 
the addition of growth factors. These results were reflected in the uptake assay where 0.1% 
treatment showed a lower Pi uptake. Interestingly, XPR1 showed an elevated expression in 
proliferative stages, and α-klotho, an aging suppressor, showed the contrary.  
Cell proliferation in EL-4 cells, under variable Pi conditions suggested that all the 
phosphate conditions above or below the positive control (6 mM) resulted in a reduced cell 
proliferation, although the optimal conditions in human body would be between 1.5 and 3 mM. 
The uptake assays showed that besides the existence or not of a sensing mechanism, cellular 
uptake depends on the Pi quantity present in the extracellular medium, which points to a less 
than perfect modulation of Pi balance. Gene expression in different phosphate conditions over 
time showed that PiT-1 and PiT-2 appear to be important for EL-4 cell proliferation, although 
their specific role was not investigated. Interestingly, XPR1 had a high expression, equivalent 
to PiT-1 and PiT-2. To respond to Pi import seems to be a similar response for Pi export to a 
response to cellular needs. 
It was confirmed the higher number of cells existent in a leukemic thymus comparing 
with wild-type, although gene expression did not make a reasonable difference, especially 
proliferating cell marker, PCNA, that showed greater expression in wild-type cells but a 
repetition of this assays is needed to assure this results. Uptake assay only confirmed the results 
in EL-4 cells, where cellular uptake depends on the Pi quantity present in the extracellular 
medium.  
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5. Future work 
For future work it would be indicated to repeat and further investigate the gene 
expression in both FBS and phosphate availability assays, to have certainty in these obtain 
results. 
In addition, it would be indicated as well to perform these cell proliferation, Pi uptake 
and quantification of the gene expression in other tumorigenic cell lines, established from other 
tissues, to have a more generalized overview of their role. 
Lastly and most important it would be to realize PiT-1 and PiT-2 knock-down or knock-
out tests in the EL-4 cell line as well in other cell lines. Using these techniques it would be 
clearer the evaluation of SLC20 family in cell proliferation. 
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Appendix  
Annex 1: Solutions 
DEPC water 
For 2 liters: A volume of 200 µL of diethylpyrocarbonate (DEPC) was added to 2 L of 
distilled water in a dark glass bottle. The mixture was agitated and left to rest for 24 h before 
autoclaved. 
 
Loading buffer 
Prepare a solution of 40% glucose in sterile water (40 g of glucose in 100 ml). When 
the glucose was dissolved was added a small amount of bromophenol blue, just to give some 
color to the solution. The solution was filter sterilize with a syringe coupled to an adapter 
filter of 0.2 µm, aliquoted and stored at -20ºC. 
 
Phosphate-buffered saline (PBS) 10x 
For 1 liter of milliQ water was added: 
 80 g of sodium chloride (NaCl); 
 2 g of potassium chloride (KCl); 
 18,05 g of sodium phosphate monobasic (NaH2PO4.H2O); 
 2,4 g of potassium dihydrogen phosphate (KH2PO4); 
The solution was filter sterilize with a filter unit adapted with a filter of 0.2 µm and 
stored at room temperature. 
 
NaHCO3 solution 0.6 M 
Dissolve 0.5 g in 10 mL of distilled water. The solution was filter sterilize with a filter 
unit adapted with a filter of 0.2 µm and stored at RT. 
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Phosphate Sorensen buffer 0,5M 
Stock solution A:  0.5 M potassium dihydrogen phosphate (KH2PO4). 
   Dissolve 0.68 g KH2PO4 in 10 mL distilled water. 
Stored at 4ºC. 
Stock solution B:  0.5 M disodium hydrogen phosphate (Na2HPO4.2H2O). 
   Dissolve 1.78 g Na2HPO4.2H2O in 20 mL distilled water. 
   Stored at RT. 
To obtain a solution at pH 7.7 (the same pH of the culture medium to were this solution 
was added) it was mixed 2 mL of solution A to 8 mL of solution B. The solution was filter 
sterilize with a filter unit adapted with a filter of 0.2 µm and stored at 4ºC.  
 
Annex 2: Alignments of the sequenced fragment with the original mRNA 
sequence obtained from NCBI (http://www.ncbi.nlm.nih.gov) 
NaPi-IIa 
 
Figure 6.1 – Clustal X2 alignment of the sequence from the database NCBI and the NaPi-IIa RT-PCR amplicon 
sequence submitted to sequencing. 
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NaPi-IIb 
 
Figure 6.2 – Clustal X2 alignment of the sequence from the database NCBI and the NaPi-IIb RT-PCR amplicon 
sequence submitted to sequencing. 
 
PiT-1 
 
Figure 6.3 – Clustal X2 alignment of the sequence from the database NCBI and the PiT-1 RT-PCR amplicon 
sequence submitted to sequencing. 
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PiT-2 
 
Figure 6.4 – Clustal X2 alignment of the sequence from the database NCBI and the PiT-2 RT-PCR amplicon 
sequence submitted to sequencing. 
 
α-Klotho 
 
Figure 6.5 – Clustal X2 alignment of the sequence from the database NCBI and the α-Klotho RT-PCR amplicon 
sequence submitted to sequencing. 
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XPR1 
 
Figure 6.6 – Clustal X2 alignment of the sequence from the database NCBI and the XPR1 RT-PCR amplicon 
sequence submitted to sequencing. 
 
PCNA 
 
Figure 6.7 – Clustal X2 alignment of the sequence from the database NCBI and the PCNA RT-PCR amplicon 
sequence submitted to sequencing. 
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18S 
 
Figure 6.8 – Clustal X2 alignment of the sequence from the database NCBI and the XPR1 RT-PCR amplicon 
sequence submitted to sequencing. 
 
 
 
 
 
 
